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Genome-scale network reconstructions serve as an ideal tool for the modeling of
large, complex metabolic networks. In this study we use flux-balance analysis to
investigate key amino acid dependencies of Plasmodium falciparum growth. Our
model was able to produce a realistic flux distribution geared for the optimal
production of biomass. We were able to simulate parasite growth in a variety of
conditions and assess the favourability of these conditions for optimal growth.
To demonstrate the applicability of the model we additionally simulate the re-
sponse of the model to the introduction of an antimalarial agent, atovaquone.
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Chapter 1
Introduction
1.1 Background and motivation
As a disease that puts almost half the world’s population at risk, malaria has
been a worldwide public health challenge [78]. In 2015 there were an estimated
212 million cases of malaria, with 429 000 of those cases estimated to have
been fatal [78]. Malaria is a mosquito-borne infectious disease caused by the
protozoan parasite, Plasmodium. Carried by the female Anopheles mosquito,
Plasmodium sporozoites are transferred to humans during a blood meal where
they infect the host’s liver and use the host nutrients to rapidly proliferate. At
this point patients remain asymptomatic. During the next phase, parasites are
released from liver cysts, entering the bloodstream in the form of merozoites,
where they will invade red blood cells and begin to reproduce asexually. It is
only once the infected erythrocytes reach the point of rupture that symptoms
will begin to present themselves. The subsequent release of burst red blood cell
contents, sequestration of infected erythrocytes to vascular endothelial cells and
a multitude of metabolic changes that occur, can lead to anaemia, fever and res-
piratory distress [68, 15, 35]. In the case of Plasmodium falciparum, there is a
risk of infection spreading to the brain, vastly diminishing the likelihood of sur-
vival and increasing the chance of permanent damage. Plasmodium falciparum
infections account for 99% of malaria-associated deaths worldwide [78]. It is for
this reason that Plasmodium falciparum will be the focus of this study. Due
to emergent resistant strains, it is of great importance that novel or improved
anti-malarial drugs and administration procedures be developed. As mentioned
1
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by Liu et al. [60], understanding of the parasite’s molecular mechanisms and
interactions are essential for the identification of new drug targets.
Mathematical modeling allows us to investigate the characteristics of Plasmod-
ium falciparum metabolism prior to conventional experimentation, enabling the
identification of significant metabolic interactions or occurrences, thus promot-
ing a more focused approach in experimental design and investigation. Fur-
thering the biochemical knowledge of this organism helps in the discovery of
potential drug targets and improving existing treatment methods. The genome
of Plasmodium falciparum has been sequenced, providing a library of parasite
proteins and regulatory elements [29, 10]. Adding to this, transcriptomic [9],
proteomic [24, 54], and metabolomic [77] studies have been conducted to further
investigate key cellular interactions and metabolic pathways. All these data are
added to specific databases that are freely available. These databases can be
used to computationally generate metabolic models that are able to simulate
an organism’s metabolism. Based on mathematical methods such as linear pro-
gramming, flux balance analysis can be used to predict the flux distributions of
a metabolic network for a specified set of conditions [22].
1.2 Aims
To date, our group has largely focused on modeling the glycolytic pathways
of P. falciparum. Using genome-scale network reconstructions we can create a
network of reactions to acquire insight into the amino acid metabolism of the
parasite, and study how these pathways interact with those of the glycolytic
pathway. A metabolic network of Plasmodium falciparum was created to simu-
late parasite growth inside a human red blood cell with a focus on amino acid
metabolism resulting from haemoglobin digestion, and the subsequent amino
acid transport dynamics as accurately as possible. From these simulations, the
following questions can be addressed:
 Is the model able to reproduce experimental observations in terms of amino
acid incorporation into biomass and amino acid export, using haemoglobin
catabolism as a primary source, and extracellular amino acid scavenging
to make up for any deficits?
 Are we able to reproduce the findings of Liu et al. [59] that Plasmodium
falciparum is able to grow in culture medium containing isoleucine as the
only supplemented amino acid?
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 Are we able to identify a steady-state flux distribution for the model sys-
tem that is realistic to what we can observe in nature?
 From the flux distribution outputs, can we identify any key reactions or
metabolites that could be investigated further as potential drug targets?
In P. falciparum metabolism, a clear dependence on specific amino acids for
the optimal growth of the parasite has been established [59, 16]. The aim of
this study was to use established biological knowledge of Plasmodium falci-
parum to construct a computational model able to simulate parasite growth
and energy metabolism, with the purpose of investigating the dependence of
each individual amino acid for the optimal rate of biomass formation. A net-
work reconstruction constructed by Plata et al. [89] was used as a foundation
to develop such a model. Their model contained 1001 compartmentalised re-
actions and 1024 metabolites, which was an adequately comprehensive network
containing all the key transport reactions, a biomass objective function, and
the incorporation of haemoglobin import into the network. The 1001 reac-
tions included comprised 75% of the total enzymatic reactions. The enzymatic
reactions removed were those with no literature support, and those not appli-
cable to biomass production. The Plata model was originally used to simulate
the effect of gene knock-outs on biomass production, and using constraints,
was able to predict direction of concentration changes for external metabolites
with 70% accuracy. Using the Plata model as a foundation meant that some
of the necessary model infrastructure would already be in place for the con-
struction of our own model. Sub-cellular localization of metabolites, substrate
and cofactor specificities, pathway gaps, and reaction directionalities were for
the most part accounted for. Using flux-balance analysis we were able to ob-
tain a flux distribution profile for amino acid and growth metabolism for a
variety of simulated conditions. Samples obtained from in vitro cultures were
subjected to amino acid analysis using UPLC separation with UV detection
(after 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate derivitization). The
metabolic fluxes were determined from the experimental data, which compared
well with model-simulated fluxes. Furthermore, we were able to make key obser-
vations into the metabolic dependencies of Plasmodium falciparum growth, and
test the response of the model to the effects of a popular antimalarial compound,
atovaquone.
Stellenbosch University  https://scholar.sun.ac.za
Chapter 2
Literature overview
2.1 Biology of Plasmodium falciparum
Malaria is a disease caused by several species of the Plasmodium genus. Clas-
sified as obligate intracellular protozoa, these parasites are dependent on a
vertebrate host for the asexual stage, and the female Anopheles mosquito,
for the sexual stage of their life-cycle. During a blood meal, mosquito saliva
containing sporozoites are transferred into the bloodstream of the host and
travel to the liver where they invade hepatocytes and proliferate to form liver-
stage schizonts. Each of these schizonts can release thousands of merozoites
[30, 31, 100, 36, 101]. It is believed that these schizonts actually bud off from
hepatocytes as membrane-bound clusters, termed merosomes [112, 109]. These
merosomes exit the liver and travel towards the lungs where they will release
merozoites into the pulmonary micro-circulation to invade host erythrocytes.
Merozoites bind to and enter erythrocytes via an apicomplexan invasion or-
ganelle [1]. During infection of the erythrocyte, the merozoite forms a vesicle
from the erythrocyte membrane [14]. The merozoite proceeds to mature into an
early trophozoite, known as the ring stage, named after the ring-like appearance
observed microscopically. The ring stage lasts about 16 hours, accounting for
one third of the erythrocytic life cycle, but has been regarded as metabolically
nondescript [32]. During the subsequent trophozoite stage, notably the most
metabolically active phase of development, the parasite will digest up to 80% of
the host cell’s haemoglobin, meanwhile growing in size [5, 70, 79]. At around the
38 hour mark of development the trophozoite will begin to undergo schizogeny,
whereby the parasite will undergo multiple rounds of mitosis to produce 15 to 30
4
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merozoites within the parasitophorous vacuole membrane, collectively referred
to as a schizont [6]. After 48 hours of development, Plasmodium falciparum
infected red blood cells will rupture, releasing merozoites into the bloodstream
to re-invade new erythrocytes. It is only in this blood-stage of infection where
clinical symptoms will present themselves.
2.2 Pathogenesis of malaria
Patients with malarial infections progressing to the blood-stage will initially
display flu-like symptoms such as fever, nausea, muscle pain and convulsions,
as well as symptoms of anemia.There is an array of factors responsible for this.
Adhesin proteins encoded by the parasite facilitate the binding of infected cells
to the blood vessel walls of the host, preventing their removal by macrophages
in the spleen. Sequestration of infected cells in the lungs (and brain in the
case of P. falciparum infections) leads to partial obstruction of blood flow, en-
dothelial barrier breakdown, and inflammation [72]. Infected erythrocytes have
a glucose uptake rate of up to 100 times higher than uninfected erythrocytes
[95]. Infection of host red blood cells also causes an immune response by the
host, whereby macrophages destroy infected cells, but also uninfected cells [43].
Reduced deformability of uninfected red blood cells and intrinsic and extrinsic
changes to these cells increase recognition by macrophages [69]. Erythrocyte
production by host bone marrow is unable to keep up [53] with this concomi-
tant loss and an anemic state will result. Anemia and various other factors
present in malaria infections will cause an insufficient oxygen supply to tissue
that may cause a metabolic shift in the host to anaerobic glucose metabolism
and increased lactic acid production [50]. Together, these shifts in metabolism
will present symptoms of hypoglycemia, lactic acidosis, and brain infection in
the case of P. falciparum.
Proteolysis of haemoglobin releases a reactive heme group. Humans have a heme
oxygenase responsible for the cleaving of heme rings, which produces biliverdin,
ferrous iron and carbon monoxide. However, Plasmodium lack the heme oxy-
genase enzyme that vertebrates use to degrade free heme. Free heme has been
shown to threaten parasite development by having the potential to inhibit en-
zyme activity [34, 41], peroxidise membranes [111], and cause oxidative free
radical accumulation in the digestive vacuole [3]. In malarial infections, host
erythrocytes are lysed at a much higher rate than normal, leading to an in-
creased amount of free heme in the host blood-stream. These free heme groups
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are detoxified by the parasite via polymerization of heme groups into inert crys-
talline structures known as hemozoin, which accumulate in the digestive vacuole.
Carbon monoxide has also been suggested to bind to ferrous iron in haemoglobin
to prevent heme release [83].
2.3 Plasmodium falciparum metabolism
2.3.1 Protein metabolism
Over a 48 hour life cycle of P. falciparum within a red blood cell, it is ac-
cepted that up to 80% of haemoglobin is digested by the parasite; however,
only about 16% of the released amino acids are actually utilised [96, 51]. The
colloid-osmotic hypothesis proposes that parasites digest host cell cytosol to pre-
vent the red blood cell reaching critical haemolytic volume (CHV) which would
result in premature lysis of the infected erythrocyte [32, 122]. During this pro-
cess, haemoglobin is rapidly degraded and the amino acids produced are largely
exported out the cell, in what would otherwise be considered a metabolically
demanding process. The increase in osmotic pressure as a result of freed amino
acids due to haemoglobin digestion alone is not enough to determine the time
of lysis of the erythrocyte. Another hypothesis is that haemoglobin degradation
necessity may also be linked to protease inhibitors [27, 57, 94, 92, 93]. Inhi-
bition of plasmepsin I and cysteine protease activity causes the haemoglobin
degradation process to halt, resulting in osmotic swelling, impairment of vacuo-
lar functions and eventually parasite death [26].
The majority of haemoglobin degradation occurs during the 6-12 hour tropho-
zoite stage [119]. New permeation pathways (NPP’s) have been shown to be
induced in the membrane of the erythrocyte [33, 48]. Mauritz et al. [67] have
hypothesised that upon entry of this metabolically intensive trophozoite stage,
NPP development is induced by the parasite. Host cell haemoglobin is ingested
by the acidic vacuole of the parasite and proteolysed to its amino acid con-
stituents. A small portion of the amino acids are retained for parasite growth
and the rest exported with the aid of these newly formed NPP’s. Plasmodia
have evolved to no longer be capable of amino acid biosynthesis, instead rely-
ing on haemoglobin catabolism and extracellular amino acid supply [29]. With
regards to Plasmodium growth, haemoglobin is a deficient source of methio-
nine, cysteine, glutamine, glutamate, and contains no isoleucine at all. This
indicates a strong likelihood that these amino acids are scavenged from extra-
cellular sources. Divo et al. [16] discovered that P. falciparum were able to
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grow in media containing only five exogenous amino acids (cysteine, glutamate,
glutamine, methionine and isoleucine). Liu et al. [59] were then further able
to show that P. falciparum is able to grow in media supplemented with only
a single amino acid, isoleucine. Isoleucine is absent from haemoglobin, and
research has shown that Plasmodia growth is not possible without the exoge-
nous supplementation of isoleucine [59]. This finding suggests that aside from




Glucose metabolism by Plasmodium spp. is achieved via the Embden-Meyerhof-
Parnas (EMP) pathway of glycolysis. Glucose is rapidly metabolised by the
parasite, up to 100 times that of uninfected erythrocytes [95]. However, around
60-70% of glucose consumed by Plasmodium is incompletely oxidised to lactate
and excreted, contrasting with the 90% glucose-to-lactate conversion observed
in uninfected erythrocytes, reflecting the increased flux of glucose-sourced car-
bon into biomass generation [42]. Only a small fraction of glucose consumed
is completely oxidized to carbon dioxide, in agreement with the belief that the
parasite tricarboxylic acid plays a minor role in energy metabolism. A hexose
transporter encoded by Plasmodium is targeted to the host cell membrane to
allow for the increased demand for glucose [102].
Tricarboxylic acid cycle
It is well established that the genome of P. falciparum encodes all the tri-
carboxylic acid (TCA) cycle enzymes and are expressed during the asexual life
stage [29, 9]. Isotopic-labelling studies have also shown this TCA cycle to be
canonical [46]. The TCA cycle is mostly fueled by acetyl-coA (and oxaloacetate,
to a smaller degree) obtained from glycolysis [108]. However, Cobbold et al. [12]
have shown that as the parasite matures, a transition towards glutamine-derived
TCA-intermediates over that obtained via glycolytic acetyl-coenzyme A (acetyl-
CoA) production, giving more evidence for an adaptive metabolism employed by
Plasmodium. Glutamine is deaminated to glutamate; where after an additional
amino group is cleaved from glutamate to produce α-ketoglutarate for use in the
TCA cycle [76]. During this process, pyruvate receives the amino group produc-
ing alanine, which ties up with the large spike in alanine export from the cell
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observed during late trophozoite stages of growth. This also coincides well with
the large consumption of glutamine released from an accelerating haemoglobin
catabolism.
Pentose phosphate pathway
The pentose phosphate pathway (PPP) is a critically conserved pathway in
almost all cells capable of of utilising carbohydrates as a carbon source. P.
falciparum is no different, and PPP-enzymes were found to be encoded in the
parasite’s genome [29], as well as expressed [9]. The PPP comprises two inter-
connected branches. The oxidative arm generates riboses required for nucleic
acid synthesis, and NADPH, a cofactor for biosynthetic reactions and redox
control. The non-oxidative arm comprises a set of reversible reactions inter-
converting 3, 4, 5, 6 and 7-carbon sugar phosphates, enabling the recycle of
ribose-5-phosphate back into glycolytic intermediates when there is an NADPH
shortage. In human red blood cells the PPP is one of the major metabolic path-
ways, consuming 3-11% of glucose metabolised under normal conditions, and is
the only source of NADPH required to reduce glutathione in response to oxida-
tive stress [121]. In trophozoite-stage infected red blood cells, the activity of the
oxidative branch increased to 78-fold that of uninfected erythrocytes [4]. In free
parasites 82% of this activity can be accounted for, indicating P. falciparum is
responsible for the majority of the flux increase, and also for the up-regulation
of of the erythrocyte-PPP by 24-fold. By up-regulating NADPH production,
the parasite is able to hamper programmed cell death initiation by the host
immune system, by maintaining a high ratio of reduced to oxidised glutathione.
2.3.3 Parasite metabolism as a target for antimalarials
The arms race between disease and treatment solutions is an ongoing war that
researchers and clinicians have fought throughout the ages. Humans have al-
ways been one step behind in this war; a constant struggle to identify new
solutions to the ever-evolving resistances that pathogens develop in response to
the cures and treatments we develop. In the case of microbial infections it is
often a question of: “What is the most efficient solution to kill the unwelcome
parasites, while doing as little harm as possible to the host?” An important fac-
tor with drug target identification strategies based on metabolomic approaches
is the differences in metabolisms of host and parasite. Blocking the availability
of metabolite X in host and pathogen could be a viable approach if the host has
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no vital requirement of metabolite X for survival, whereas even a 10% disrup-
tion in metabolite Y production or depletion might kill both host and parasite.
Therefore core strategies often initially require the identification of differences
in metabolic network structure as well as robustness to change thereof.
Unlike the majority of eukaryotic cells, Plasmodia species do not rely on mito-
chondrial electron transport systems for ATP production. However, inhibition
of the Cyt bc1 complex of electron transport is usually lethal to the parasite,
due to interruption of pyrimidine biosynthesis and destabilisation of mitochon-
drial membrane potential [65, 66, 115]. An observation was made by Painter
et al. [81] that P. falciparum likely maintain mitochondrial electron chain ac-
tivity for the sole metabolic purpose of regenerating ubiquinone, the electron
acceptor of dihydroorotate dehydrogenase (DHODH). DHODH is responsible
for the oxidation of dihydrooorotate to orotate, and is an essential reaction in
the synthesis of pyrimidines required for DNA synthesis. Atovaquone, an analog
of ubiquinone, has been used in conjunction with proguinil in the drug malarone
for the treatment of malaria since 2000. Atovaquone occupies the quinol oxidase
site of mitochondrial Cyt b, inhibiting the electron flux through the Cyt bc1
complex thereby preventing pyrimidine biosynthesis and collapse of mitochon-
drial membranes. At concentrations as low as 5 nM, atovaquone is still able to
inhibit 90% of DHODH activity [40].
2.4 Mathematical models and metabolism
Mathematical modeling has been used as a powerful predictive tool across a
diverse spectrum of fields including the natural sciences, engineering, economics
and social sciences. In biology, metabolic networks can be described mathe-
matically, using sets of equations to represent network reactions and a set of
variables that define the metabolic environment. The model, represented as a
set of functions describing interactions between variables, is optimised for a de-
sired set of conditions and a set of prediction outputs are acquired. The fact that
a metabolic environment can be defined means that modeling has implications
in physiological studies, pathway gap-filling and flux manipulation in biologi-
cal systems [80]. For example, by constraining certain reactions in a bacterial
species, we can simulate a growth medium or even gene knock-outs and then
use a mathematical approach such as flux balance analysis (FBA), to predict
the yield of key metabolites and cofactors.
As biological systems consist of a number of low-level components acting to-
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gether to display high-level system behaviour, when we construct a mathemat-
ical model of a biological system, there are two approaches. A bottom-up ap-
proach involves analysis of the detailed experimental data of the components and
their interactions and then including only what is deemed necessary. This type
of model is not fitted on the system behavior, but rather predicts the behaviour
of the system as a function of the interacting components. Alternatively, a top-
down approach uses measured system behaviour to construct a model consisting
of apriori selected mechanisms. Method choice is based on the purpose of the
model and the experimental data available, however a combination of the two
approaches can be used during the construction of a mathematical model.
Depending on the scope of the project, a researcher must also determine the
elements required of their model for their investigations. Static models are time-
invariant and calculate the flux distribution of the system in equilibrium (steady-
state), whereas a dynamic models are able to account for time-dependent changes
in the system. This often becomes a question of model complexity. Based on
the size of the model and the available data, complexity is an important consid-
eration during model design, and boils down to a trade-off between simplicity
and accuracy. Metabolic models tend to either contain only a few metabolic re-
actions described to high kinetic detail (kinetic models) or comprise a large set
of reactions with little or no kinetic detail (stochiometric, or constraint-based
models). Large models such as genome-scale network reconstructions may seem
more biologically relevant as they can account for global inter-dependencies and
the effects of multiple linked metabolisms and compartments, but this is often
accompanied by the lack of kinetic data leading to a lower model resolution.
The yeast consensus model contains more than 1000 reactions, but merely de-
fine the network stoichiometry, which can only be studied using Elementary
Mode Analysis or Flux Balance Analysis [106]. Kinetic models on the other
hand are limited to a smaller number of reactions due to computational issues,
such as numerical instability and the computational costs of higher resolution
simulations.
There are many kinetic models of yeast as well, however their coverage does
not extend far beyond the glycolytic pathway and typically comprise less than
20 reactions, but allow for dynamic simulations and metabolic control analysis.
Ideally it would be desirable to construct genome-scale kinetic models, and
attempts have been made to do this using methodologies such as linlog rate laws
or approximation methodologies, whereby generic rate laws are incorporated
[103, 104]. The current methodologies however, do not produce models of a
satisfactory calibre and research on this topic is ongoing. Therefore, depending
on the focus of the research, when initiating model design at this point in time,
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a researcher must decide on a top-down or bottom-up approach and whether to
define enzyme kinetics for the model.
2.5 Genome-scale network reconstructions of
biochemical networks as an approach to
modeling metabolism
2.5.1 Establishing a genome-scale network reconstruction
Traditionally, metabolic network reconstructions were based on primary liter-
ature and biochemical characterization [64, 84, 85]. Today, thanks to high-
throughput sequencing, we are able to sequence and annotate on a genome
level, allowing the creation of genome-scale network reconstructions. This can
even be done for organisms with minimal published biochemical data. Network
reconstructions consist of a network of linked reactions that are mass-balanced
and the system is at steady-state. To construct a network reconstruction, cer-
tain knowledge of the enzymes catalysing each reaction is required. For each
enzyme, the actionable substrates and products and the stoichiometric coeffi-
cients of each metabolite participating in said reaction needs to be known. In
practice, these reconstructions occur using automated software to map out data
from bibliomic databases. Organism-specific genome annotations can be found
in genomic databases such as EcoCyc [116] and SGD [45]. These genome anno-
tations are each directly linked to a metabolic enzyme and indicate how these
gene products interact and catalyze metabolic reactions in the network.
Metabolic databases such as KEGG [44] and Transport DB [91] are used to
assign reaction specificity to each of the enzymes present in the system. Many
of these databases link an enzyme commission (EC) number or transport com-
mission (TC) number to reactions observed in a different organism to that of
the model. It is, however, important to note that substrate specificities and
enzyme activities can differ between enzymes with the same EC or TC number.
Additionally, key information required for the network reconstruction, such as
sub-cellular localization and reaction directionality, may not be present. This
highlights the importance of curating the initial reconstruction.
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2.5.2 Curating the network reconstruction
Automatically reconstructed networks will often be incomplete and require man-
ual curation. There will often be reaction gaps or reaction mismatches, and this
can be quite a tedious procedure. Using available literature, organism-specific
databases and even consultations with experts that have specialist knowledge
of the organism, reaction errors and gaps can be solved. These curated network
reconstructions build on the biochemical, genomically and genetically (BiGG)
structured knowledge base available to all researchers working on the target or-
ganism. The reactions placed in a BiGG knowledge base form a genome-scale
network reconstruction (GENRE). These GENREs are formed iteratively as new
experimental data is released and the BiGG knowledge base grows [22].
2.5.3 Transforming a genome-scale reconstruction into a
computational model
Before a network reconstruction can be used to make simulations, it needs to
be converted into a mathematical format that can be computationally read.
Converting a GENRE to a genome-scale model (GEM), opens up the model to
computational tools that can be used to evaluate the network in its ability to
accurately predict outcomes, and where necessary, make changes to the network
to more accurately align these prediction outcomes with published data. Neces-
sary for these analyses, is the composition of cellular biomass, the composition
of minimal growth media, and a set of experimental data which includes growth
rates and substrate uptake rates of the specific organism under a specified set
of conditions.
Once in a GEM format, a biomass objective function can be applied to simulate
the ability of the network to support growth. The biomass objective function is
an artificial reaction added to the model as a representation of the macromolec-
ular components required to synthesize a model-defined amount of an organism.
Most commonly, it is the millimole of each component required to form a gram
of organism dry weight. Chavali et al. [11] describes an approach whereby
the dry weight distribution of protein, carbohydrate, DNA, RNA, lipid, and
polyamine percentage is determined experimentally or via available literature of
the organism or similar organisms. The relative abundance of each molecular
component comprising each macro component can then be estimated based on
its percentage prevalence. For example, in Leishmania major, Chavali et al. [11]
estimated that the protein fraction constituted about 45 % of the organism dry
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weight. To determine the amount of arginine in this fraction, the amino acid
sequences associated with each open-reading frame in the L. major genome can
be acquired from GeneDB. Using the percentage prevalence of each amino acid
and each respective molecular weight, we can determine a dry weight distri-
bution for the various amino acids. At a percentage prevalence of 7.19 and a
molecular weight of 175.11 g/mole, we can calculate the total mass contribution
of arginine as 9.95%. This can then be converted to a mmol/gDW value, indi-
cating the millimole demand of each metabolite to form one gram of dry weight
biomass.
There are additional factors to consider during model curation, being that of
strain-specific parameters and non-metabolic activities. For example, the stoi-
chiometry of translocation reactions and cell maintenance reactions are major
factors that need to be acknowledged [21, 117]. Translocation reactions often
need to be considered post-reconstruction as a result of the difficulty to experi-
mentally obtain data on the mass and energy balances of ion-pump components
[22]. To analyse the accuracy of the modeled network reconstruction, model
simulations can be conducted for a specified set of conditions, of which experi-
mental data has already been published.
2.5.4 Large-scale data processing of genome-scale models
Completed GENREs and GEMs can be integrated to cover a range of cellu-
lar activities with a single model. Network reconstructions can be performed
on a variety of an organism’s cellular activities. In addition to metabolic pro-
cesses, network reconstructions can be applied to transcriptional and translation
processes, transcriptional regulation, and other signaling systems. Once multi-
ple types of network reconstructions have been established for a given organ-
ism, these network reconstructions can be integrated to evaluate genome-scale
’omics data sets with a higher biological relevancy and accuracy. Integration of
transcriptional regulation networks (TRNs) and metabolic networks has been a
popular choice for researchers [13, 37, 55]. TRNs add an extra step of regula-
tion as active enzyme concentrations are regulated by transcriptional activity.
In turn, gene expression is regulated by metabolic precursors of transcription,
and a kind of positive feedback is established. The same approach has been
taken with integration of sRNA (small RNA) into genomic models. One of the
functions of sRNAs is to regulate gene expression through mRNA binding, thus
acting together with transcriptional regulation to determine eventual enzyme
expression.
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2.6 Flux balance analysis as a mathematical
approach to biological problems
In biochemistry, flux balance analysis (FBA) is a widely used approach for
modeling genome-scale biochemical networks [18, 21, 23, 75]. By means of linear
programming, FBA mathematically analyses the flow of metabolites through a
metabolic network, allowing for the prediction of metabolic outcomes for a given
set of parameters. For example, given a set of constraints, FBA can be used to
predict the growth rate of an organism for a specific set of biological conditions.
In a simplistic 2-step reaction, a substrate “S”, will be converted by enzyme “E1”
into an intermediate metabolite “X”. Enzyme “E2” will then convert metabolite
“X” into product “P”.
In this reaction the rate of production of product “P” is dependent on how
fast enzyme “E1” can convert substrate “S” into intermediate “X”, and how fast
enzyme “E2” can convert intermediate “X” into product “P”. At steady-state,
these reaction rates are known as steady-state fluxes. Considering the activities
of “E1” and “E2”, whichever enzyme has the slowest activity will determine the
rate at which “P” can be formed. Even if “E1” is able to convert 5 “S” to 5 “X”
per minute, if “E2” is only able to convert 2 “X” to 2 “P” per minute, only 2
“P” can be produced every minute. The same is true for vice versa. If “E2” is
able to convert 5 “X” to 5 “S” per minute, but “E1” is only supplying 2 “X” per
minute, only 2 “P” will be produced per minute. This rate-limiting effect on “P”
production by enzyme “E1” or “E2”, is known as a system constraint.
If we expand our simple reaction network further, introducing a third enzyme,
which competes with enzyme “E2” for intermediate “X”, there will be two pos-
sible end-products that can be formed from metabolite “X”.
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In a dynamic system, the concentrations of substrate “S”, and products “P” and
“Y” can affect the reaction rates. In a system consisting only of a saturating
concentration of substrate “S”, reaction throughput by the “E1”, “E2” and “E3”
reactions will be a lot higher than a system where there is very little available
substrate“S”and say, a high concentration of metabolite“X”. Assuming reaction
“E1” is reversible, the presence of a large concentration of “X” and a low con-
centration of substrate “S”, may push the reaction flux in the reverse direction,
producing “S” from “X”. A reaction network is said to be at steady-state when
the concentrations of internal metabolites reach a stable concentration, and each
reaction displays a constant, net flux. When this system is at steady-state, de-
pending on reaction favourabilities, there will be a flux distribution between
enzymes “E2” and “E3”, represented as steady-state fluxes “J2” and “J3”. As
intermediate “X” can only be consumed as fast as it can be produced, the sum
of “J2” and “J3” will thus equal “J1”.
J1 = J2 + J3
There can be multiple different flux distributions for “J2” and “J3”, all fulfill-
ing J1 = J2 + J3. We may wish to optimise the production of metabolite “Y”.
In a modeled system, we could set an objective function for the production of
metabolite “Y”, and using FBA, find the most optimal solution for maximizing
the rate of “Y” production.
A simplistic branched metabolic pathway can be used to illustrate glycolysis
in yeast. During glycolysis, glucose is processed by a pathway of consecutive
reactions to form pyruvate. Depending on the growth conditions of a yeast
cell, pyruvate (“X”) can either undergo aerobic metabolism, converting pyru-
vate into acetyl-coA, or undergo anaerobic fermentation, whereby pyruvate is
processed into ethanol. For the sake of simplicity, the glycolytic pathway has
been condensed into a single reaction step.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. LITERATURE OVERVIEW 16
Each enzyme in the metabolic network will have a maximal and minimal activity.
This is known as the upper and lower bounds, and serves as a flux constraint
for each reaction. Depending on the parameters we set for a modeled system of
yeast metabolism, FBA will determine a flux-distribution for the fate of pyruvate
molecules produced by glycolysis. One may wish to optimise their network
so that the yeast cell favours ethanol production over aerobic respiration. An
objective function for the model can be set to optimise the production of ethanol.
Using FBA, an optimal solution space can be calculated for the model, which can
reveal key factors responsible for optimising ethanol production. Once a stable,
working model has been achieved, a variety of new conditions for the modeled
yeast cell can be tested. For example, one can simulate a hypothetical GMO-
yeast strain that produces a lower concentration of pyruvate dehydrogenase
complex enzymes by constraining the flux through this pathway in the model,
and test whether this decrease in enzyme concentration will lead to a higher
portion of pyruvate being converted to ethanol than acetyl-coA.
2.6.1 FBA and biology
Using experimental data obtained from various databases, such as KEGG [44],
BRENDA [98] and MetaCyc [49], we are able to generate a network recon-
struction. These days automated software is readily available that can perform
this task efficiently. When converting a metabolic network reconstruction into a
computational model, the first step is to mathematically represent the metabolic
reactions of the model. This is done by setting up a numerical matrix of the
stoichiometric coefficients of each reaction (figure 1b). From this numerical ma-
trix, a system of linear equations can be derived, representing the stoichiometry
of each reaction in the network. This set of mass balance equations act as
constraints ensuring that the total amount of any metabolite produced must
be equal to the total amount consumed at steady state. This is also the first
constraint that is applied to the model.
The second constraint on the system comes in the form of upper and lower
bounds applied to each reaction in the model (figure 1c). These bounds define
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the maximum and minimum allowable flux for each reaction. Reaction flux is a
representation of the rate at which each metabolite is consumed or produced by
each reaction. These two types of constraints together define the possible flux
distributions for a system, also known as the solution space.
Fig.1 A network reconstruction consisting of metabolic pathways (a) is repre-
sented in the form of a stoichiometric matrix (b), where each column dis-
plays a reaction in the network, and each row displays the list of metabo-
lites involved in the network. To analyse growth from model simulations,
an additional column representing an artificial biomass reaction can be
added. Stoichiometric coefficients are assigned to metabolites for each
reaction. An upper and lower bound is applied to each reaction (c), defin-
ing the maximal and minimal allowable flux through each reaction in the
pathway [7].
Most biological network reconstructions are large models where there are more
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reactions than metabolites, meaning there is more than one possible solution to
the set of linear equations. It is thus necessary to use some kind of optimisation
technique to find the optimal solutions. To investigate a desired phenotype in
a model, an objective function is defined, which will either be maximised or
minimised mathematically. A desired phenotype is investigated by setting an
objective function for the model and applying the necessary constraints to the
model. For example, for predicting growth rate of an organism, the objective
set would be a reaction representing biomass production. In the case of biomass
production, an artificial ’biomass reaction’ is created that mathematically rep-
resents the rate at which metabolites are converted into biomass constituents.
In terms of the stoichiometric matrix, an extra column is thus introduced con-
taining stoichiometric values for metabolic constituents that are consumed to
simulate biomass production. The composition of this biomass reaction is based
on experimental data on biomass components, such as nucleic acids, proteins
and lipids. The biomass flux is scaled to the exponential growth rate (µ) of the
organism. Predicting the maximum possible growth rate can then be achieved
by using FBA to calculate the possible conditions that will result in the max-
imum flux through the biomass reaction. It is possible that multiple reactions
contribute to a phenotype of interest. Mathematically, an objective function
quantitatively determines how much each reaction contributes to a phenotype.
Linear programming algorithms are used to solve for optimal solutions for a
modeled set of conditions. Due to the size of most models, computational lin-
ear programming algorithms are necessary to solve for these solutions. Many
of these computational algorithms are freely available on the internet or on re-
quest by author. Algorithm software, such as the COBRA Toolbox, is able to
efficiently solve for optimal solutions to large systems of equations [7]. FBA can
also be used to determine a phenotype for a variety of conditions. Constraints
can be altered by adjusting the bounds of reactions in the system. Growth rates
of an organism can thus be simulated for a range of substrate conversion rates.
2.6.2 Linear programming: The foundation of FBA
Linear programming is a method of optimising a mathematical model, where
all variables are represented by linear relationships. An objective function is as-
signed and optimized, while confined to the linear equality and linear inequality
constraints defined in the model.
Linear problems can be expressed mathematically in a canonical form:
 maximise Z = cTv
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 subject to Sv ≤ b
 and v ≥ 0
where “v” represents the vector of all the variables and “c” defines the weighting
of each flux in the objective function. “b“ Is the vector of all the constraints,
“S” is the matrix of coefficients and “(.)T” is the matrix transpose. “cTv” Is the
expression being optimized ie. the objective function. The inequalities “Sv ≤
b” and “v ≥ 0” are the constraints depicting the convex polytope over which
the objective function is to be optimized. This convex polytope serves as a
graphical illustration of the solution space of the model ie. all the possible
model outcomes, based on the array of possible flux distributions (figure 2).
Returning to our simplistic branched metabolic pathway, we can illustrate the
principles of linear programming.
Our linear objective function is to maximize the production of ethanol. By
increasing the proportion of pyruvate produced via pyruvate kinase activity
(PYK) consumed by pyruvate decarboxylase (PD) rather than by the pyru-
vate dehydrogenase complex (PDC), more acetaldehyde can be produced. More
acetaldehyde means more ethanol can be produced by alcohol dehydrogenase
(ADH).
Glycolysis produces two quantities of pyruvate for every quantity of glucose con-
sumed. The stoichiometry of a reaction network directly applies to the reaction
fluxes observed, and as a result, the rate of pyruvate formation is effectively dou-
ble that of the glucose consumption for a given glycolytic flux. All downstream
fluxes will also be affected by this stoichiometric factor and so it is acknowledged
when writing out our objective function:
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maximize PD: 2 vPD = vPYK - 2 vPDC
with the following constraints:
2 vPD + 2 vPDC ≤ vPYK
The rate of pyruvate consumption between the PDC and PD reactions can
only be equal to, or less than half the rate of glycolysis.
- 0.5 vPYK + vPD ≤ - vPDC
The total flux through PDC must be equal to or less than 50% of the gly-
colytic flux minus the flux through the PD branch
- 0.5 vPYK + vPDC ≤ - vPD
Similarly to the PDC reaction constraint above, the total flux through PD must
be equal to or less than 50% of the glycolytic flux minus the flux through the
PDC branch
- vPD ≤ - vADH
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v2ADH ≥0
These non-negative constraints define that the reactions PYK, PD, and ADH
cannot have negative flux values. Basically, in order to maximise the production
of acetaldehyde, it is required that these three reactions have a non-negative net
flux.
More complex linear programs are usually expressed in matrix form:
max{cTv | Sv ≤ b λ v ≥ 0}
As described earlier, our objective function “cTv” or “Z” is maximised, within
the feasible solution space created by the constraints “Sv ≤ b” and “v ≥ 0”.
























In an FBA-based model, the stochiometric matrix (“S”) will consist of rows
of reactions (“n”) and columns of metabolites (“m”), representing the quantity
of each metabolite consumed and produced for every network reaction (figure
1b). The vector of all the reaction fluxes (“v”) is multiplied through the rows
of reactions in the stochiometric (“S”) matrix (“S x v”). These outputs are
constrained by the system of inequalities “Sv ≤ b” and “v ≥ 0”, which together
define a set of minimal and maximal bounds for each reaction flux (figure 1c).
Based on the bound-restrictions established for each reaction, we can graphically
display the reaction vectors and map out a feasible region (figure 2).
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By factoring in our constraints, a solution space is defined in the form of a convex
polytope. This solution space is more commonly referred to as the feasible re-
gion. To solve for optimal solutions to an established objective function (“Z”), a
linear programming algorithm can solve for the points in this polyhedron where
the objective function value is optimal (either maximised or minimised).
Fig2. Before applying constraints, the solution space (feasible region) is limit-
less, but after applying constraints in the form of linear inequalities, an
allowable solution space is established. Linear programming algorithms
then work to find optimal solutions for the system along the edge of the
feasible region [80].
With just four reactions and five metabolites in the example above, there are
only a handful of variables that can affect the outcome in the optimization of
ethanol production. One could determine an optimal solution using just a pen
and paper. However, in reality, biological systems are far more complex and
the number of reactions can extend into the hundreds and thousands, each with
minimal and maximal allowable fluxes (bounds). The potential outcomes of such
a system can get exponentially more complex with the introduction of each new
variable. There is thus a need for a higher solving power than a man and his pen
and paper. Today we make use of solving-algorithms based on the principles
of linear optimization to simulate feasible solutions to computationally-modeled
systems.
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2.7 Genome-scale network reconstructions,
then and now
Before the existence of GENREs, constraint-based modeling was used as a
method to determine theoretical pathway yields and metabolite overflows for
simple metabolic pathways. The ability to sequence whole genomes made it
possible to utilise constraint-based modeling at a genome scale, allowing for the
assessment of phenotypic functions based on the complete metabolic gene con-
tent of an organism. The first GENRE was built for Haemophilus influenzae in
1999, demonstrating that the genotype-to-phenotype relationship of metabolic
pathways could be discerned mechanistically at a genome-scale [20]. GENREs of
model organisms followed soon after, consistently being updated and improved
as modeling techniques became more sophisticated and additional data became
available. Updates to the GENRE for Escherichia coli brought about the de-
velopment of a set of standards for modeling the relationship between genes,
proteins and reactions involved in a particular biochemical transformation [90].
Later, updates to the GENRE for Saccharomyces cerevisiae suggested a stan-
dard way to describe cellular compartmentalisation [25]. The development of
these guidelines facilitated the study of global organization of cellular behavior,
such as pathway structure [107], adaptive evolution end points [39], metabolic
fluxes [2] and bacterial evolution [82, 86].
The age of “omic” data opened the door to much richer, diverse GENREs. The
ability to compare transcriptional changes for a given metabolic network allowed
for context-specific modeling, and further aided accuracy in these models. As
a result, reconstructions of dynamic metabolism such as human metabolisms
[18, 113] and photosynthetic processes [74] were now possible.
Today, highly curated and validated GENREs enable meaningful predictions of
biological processes. Lobel et al. [62] investigated the role of metabolism in
the pathogenesis of Listeria monocytogenes. Through constraint-based model-
ing they were able to contextualize expression data and algorithmically correct
for incorrectly up-regulated transcripts where the rest of the associated path-
way is inactive. This higher predictive accuracy enabled the research group
to focus their experimentation on highly active pathways and to elucidate the
role of amino acid metabolism in L. monocytogenes pathogenesis via knockout-
strain simulations. Interaction networks describe the phenomological interac-
tions between different biomolecules, such as genes, proteins and transcription
factors. Szappanos et al. [110] were able to discover the mechanistic prin-
ciples that underlie the global properties of S. cerevisiae genetic interaction
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 2. LITERATURE OVERVIEW 24
networks. Through the use of single-deletion mutants, they were able to disrupt
the production of multiple metabolite precursors necessary for cellular growth
and show the contribution of associated gene interactions in the functionality of
certain genes. As a result, model refinement led to the identification of one of
two NAD+ biosynthetic pathways from amino acids in their model as a source
of inaccurate predictions. Growth experiments using mutant strains were able
to confirm that this second biosynthetic pathway was not present in Saccha-
romyces cerevisiae. Nakahigashi et al. [71] discovered a novel pathway and
previously uncharacterized enzymatic functions in Escherichia coli directly as
a result of genetic perturbation simulations to the central carbon system of E.
coli. This prompted experimentation with a variety of knockout-strains of E.
coli. Metabolomic analysis identified a metabolite previously uncharacterized
in E. coli, “sedoheptulose-1,7-biphosphate”, suggesting a novel reaction. It was
found that phosphofructokinase carries out this reaction and that glycolytic al-
dolase can split the seven-carbon sugar into three- and four-carbon sugars. In
short, the use of constraint-based modeling led to the discovery of two new
catalytic functions of classic glycolytic enzymes.
GENREs have also aided in the field of metabolic phenotype design and bio-
chemical engineering. Yim et al. [120] designed an E. coli strain able to produce
1,4-butanediol (BDO) at high yields. This is a significant feat, considering BDO
is not a naturally occurring compound in any organism. The authors used a
pathway prediction algorithm to determine the necessary transformations re-
quired to convert an endogenous E. coli metabolite to BDO. Using FBA they
were able to identify the most favourable pathway based on thermodynamic
feasibility, theoretical yield, and topological distance of the pathway from the
central carbon system. Another hurdle was getting E. coli to produce BDO at a
significant rate. Using a knock-out algorithm, a strategy was developed to block
out the production of natural fermentation products, forcing the organism to
channel carbon flux through BDO production in order to maintain redox bal-
ance. The use of constraint-based modeling greatly accelerated the industrial
strain design process.
Conventional drug target discovery is based on gene-centric constraints. How-
ever, metabolite- and reaction-knockouts are also possible. Using a metabolite-
centric approach, enabled Kim et al. [47] to search for structural analogues
of metabolites essential to the Gram-negative pathogen, Vibrio vulnificus, that
would inhibit the enzymes that relied on them as substrates. Using a constraint-
based model they were able to approach antibiotic discovery from multiple per-
spectives, and as a result, a compound more effective than current anti-bacterials
was identified experimentally.
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GENREs and constraint-based modeling has also led to the coupling of vari-
ous cellular processes. Lerman et al. [56] integrated a model of Thermotoga
maritima metabolism with another model of transcription and translation. The
hopes are that an integrated model may address some of the challenges that
limited metabolic models face. This integrated model is able to account for the
variability of cellular composition at different growth rates, whereas metabolic
models only use a biomass function for growth rate optimization. The authors
were able to validate predictions of differential experimental transcriptome and
proteome levels across varying conditions. With GENRE models such as these,
as the content of these models increase the ability of such models to explain and
predict biological functions grows in scope.
2.8 Network reconstruction curation conducted
by Plata et al.
A network reconstruction was created by Plata et al.[89] to simulate biomass
production rates and changes in metabolite exchange reactions as a result of
single and double gene deletions. In their model, enzyme-coding genes of P.
falciparum were mapped to their corresponding metabolic reactions using well-
studied metabolic models, such as the iAF1260 model for E. coli, the iND750
model for S. cerevisiae and the genome-scale human metabolic network by
Duarte et al [19]. Additional mapping was conducted using the KEGG database.
Stoichiometry and compartmentalisation of reactions were conducted. Trans-
port and exchange reactions were added based on PlasmoDB and MPMP databases,
as well as additional literature reported values. A biomass-producing objective
function was created and added to the model based on a modified version of
the yeast objective function found in the iND750 model [19]. Lipid composition
was modified as reported for Plasmodium by Hsiao et al [38]. Amino acid and
nucleotide components were adjusted based on proteome and genome expres-
sion data obtained by Llinas et al. [61]. The percentage prevalence of each
ribonucleotide and amino acid across all open reading frames (ORFs) was cal-
culated as the relative frequency of each monomer. Where available, the counts
for each ORF were multiplied by their expression levels. The percentage preva-
lence of dNTPs was derived from the genome A+T content of 80.6% and then
converted to mmol/gDW as described by Chavali et al [11]. Once the network
reconstruction was able to synthesize or import all biomass components, the
reactions with no literature support and not essential for biomass production
were removed from the network.
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3.1 Setting up an initial model
A literature search of published genome-scale network reconstructions of P. fal-
ciparum metabolism was conducted. FAME is web-based modeling tool that
combines the tasks of creating, editing, running, and analyzing/visualizing stoi-
chiometric models into a single program [8]. Appropriate models were analysed
using the FAME modeling tool, and compared using a set of criteria:
 Does the model contain all the key reactions and metabolites required to
accurately simulate intra-erythrocytic P. falciparum growth?
 Are all the necessary transport reactions included in the model?
 Are the network reactions compartmentalised?
 Does the model include a biomass objective function to represent parasite
growth?
 Does the model include a haemoglobin import function?
3.2 Model curation
Using the framework of a selected network reconstruction, we constructed our
model with a focus on the amino acid metabolism in P. falciparum. We set a
26
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maximum biomass formation rate based on a determined specific growth rate as
well as a maximum rate that haemoglobin can be digested for amino acid supply
to the parasite. We then set objective functions on biomass formation rate,
haemoglobin catabolism and glucose consumption. Based on model simulation
outputs, we assessed the flux outputs of the model and applied constraints to
the model to address any model stability issues. This process was repeated
multiple times to test the response of the model to the applied constraints.
Model simulations were conducted in the Python programming language, and
using the COnstraints-Based Reconstruction and Analysis for Python (CO-
BRA) toolbox [97]. Additional packages were installed including LMFIT, MAT-
PLOTLIB, NETWORKX, NUMPY, LIBSBML, SCIPY AND SYMPY.
3.3 Parasite culturing
P. falciparum (Strain D10) cultures were grown in airtight, standard 250 mL
culturing flasks containing 50 mL of RPMI 1640 formulation 6504 medium
(10.4 g/L) supplemented with 0.5% m/v Albumax II ®, 22.2 mM glucose (33.3
mM glucose final concentration), 25 mM HEPES, 3 mM hypoxanthine, 25 mM
sodium bicarbonate, and 50 µg/mL gentamycin sulphate, and pH 7.2 at 37 oC ,
as described by Trager & Jensen [114]. Cultures were maintained at 4% haema-
tocrit (A+ erythrocytes obtained from anonymous donors through the Western
Province Blood Bank, South Africa) and a gas mixture consisting of 3% oxygen,
4% carbon dioxide, and 93% nitrogen, was used to aerate cultures. All reagents
were obtained from Sigma-Aldrich (St. Louis, Missouri, USA), unless otherwise
stated. RBC’s were washed twice in standard medium before incubation.
Culture synchronization was conducted using sorbitol synchronization as de-
scribed by Lambros and Vanderberg [52] leaving only ring-infected and unin-
fected RBC’s intact. The more mature life stage infected RBCs, containing
trophozoites and schizonts would be lysed. Centrifuge-isolated (750 x g, 3 min)
infected erythrocytes were suspended in a pre-warmed, sterile sorbitol solution
in distilled water (5%) at 37 oC for 5 minutes. This creates a 16 hour window of
synchronisation approximately (ring stage parasites are observed between the
6 to 22 hour time points in the 48 hour life cycle). Tighter synchronisation
windows were obtained using multiple synchronisations at start and endpoints
of ring stage, allowing for approximately 90% uniformity in a synchronisation
window of about 4 hours.
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3.4 Growing P. falciparum parasites on a
minimal medium
The minimal media used by Liu et al. [59] was recreated to test haemoglobin-
dependent growth of erythrocytic parasites. RPMI 1640 formulation R8999-04A
(US Biological) w/o amino acids and sodium phosphate was used as the base
media. R8999-O4A RPMI media (8.59 g/L) was supplemented as in the stan-
dard culture media, but with the addition of 0.8 g/L sodium phosphate dibasic
that was lacking in the custom formulation. Single amino acids were added in a
variety of combinations to test the dependence of parasite growth on the pres-
ence of key amino acids (isoleucine, methionine, glutamine, glutamate, cysteine;
Sigma-Aldrich). Amino acids concentrations were based on the concentrations
found in standard RPMI 1640 media formulation. The pH was adjusted to 7.2
at 37 oC for all custom media created.
3.5 48 Hour life cycle sampling of cultured
parasites
After sorbitol-synchronisation of parasites, there is a possibility that parasite
growth may be affected (metabolic stress). For this reason, parasites were
allowed an additional life cycle to be sure parasite growth was stable post-
synchronisation. Parasitemia change and synchronicity was monitored micro-
scopically via blood-slides. Synchronised parasites used for experimentation
were harvested during early schizont stage and split into two triplicate lines;
one line of triplicates representing low parasitemia (9%) growth, and the other,
high parasitemia (21%). Culture lines were split in the schizont stage (40-44h
life-stage), accounting for an established 4x multiplication factor during par-
asite re-invasion. The motivation behind schizont stage splitting is to avoid
parasite loss present in early merozoite based splitting, whereby newly released
merozoites that have not re-invaded yet are lost during parasite harvesting. A
0h timepoint was sampled immediately after culture splitting. Parasites were
allowed to re-invade new red blood cells and timepoint-based sampling was con-
tinued at: 24h; 36h; 48h post-split. Samples were immediately flash-frozen in
liquid nitrogen and stored at -20 oC. Important to note is that culture media
was refreshed after the 24 hour sample point, as 48 hour experiments with no
media refresh showed stressed growth not long after 24 hours of incubation for
both low and high parasitemia counts. Stressed growth was observed by the
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change in colour of culture medium from a bright red to a dark, brownish-red.
When microscopically inspected, some intra-erythrocytic parasites appeared as
dark, solid balls, often observed in cultures under metabolic stress. This is due
to hemozoin accumulation and the pH drop resulting from lactic acid accumu-
lation.
3.6 Extracellular amino acid analysis using
UPLC-UV
Timepoint samples used for analysis were defrosted and centrifuged at 1200 x
g for 5 minutes to remove large particulate matter and macromolecules. Su-
pernatants were transferred to Nanosep 10K Omega centrifugal devices (PALL
Life Sciences ®) for finer filtration to isolate extracellular amino acids by cen-
trifugation at 14000 x g for 12 minutes. Supernatants were then submitted to
Central Analytical Facility at Stellenbosch University, South Africa for amino
acid analysis. Submitted samples were subjected to the Waters AccQ Tag Ultra
Derivatization Kit and placed in a heating block for 10 minutes at 55 oC. Amino
acid separation and detection was performed using a Waters Acquity Ultra Per-
formance Liquid Chromatograph (UPLC) fitted with a photodiode array (PDA)
detector. A Waters UltraTag C18 (1.7 µm, 2.1 x 50 mm) column was used for
the separation, and instrument control and data acquisition was performed by
MassLynx software, which integrates the peaks at the defined retention times
and plots calibration curves for each amino acid based on the peak response
(peak area/internal standard peak area) against concentration. UPLC parame-
ters were as follows: 700 µL/min flow rate, water as solvent A, and acetonitrile
as solvent B.
3.7 Model validation
3.7.1 Evaluating model prediction accuracy by
comparison to flux values obtained via
experimental data
We established objective functions for our model, applied a set of reaction con-
straints for general model stability and addressed model errors that occurred,
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such as infinite-looping of metabolites. We then validated our model simula-
tions by comparing our model outputs with experimental fluxes obtained from
a UPLC data set.
3.7.2 Simulation of atovaquone, a popular antimalarial
At concentrations as low as 5 nM, atovaquone has been shown to be able to
inhibit 90% of dihydroorotate dehydrogenase (DHODH) activity in previous
experimentation[40]. In our model a reaction named “DHORD2 mt” repre-
sents the activity of mitochondrial DHODH, responsible for the oxidation of
dihydroorotate to orotate. As atovaquone ultimately affects the oxidation of
dihydroorotate to orotate by hampering mitochondrial DHODH activity, we
simulated the effect of the drug by constraining the flux through this reaction
in the model to investigate how biomass production is affected.
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Results
In this chapter we will present the results of our model simulations as well as
the results of our experimental work. In literature claims have been made that
P. falciparum could be grown quite efficiently on a variety of nutrient-restricted
media [16, 99, 58]. This is a significant aspect in the investigation of the role of
amino acid metabolism in biomass production. We will first present the results
of our culturing of P. falciparum on a variety of nutrient-restricted media, fol-
lowed by the UPLC-UV analysis of standard cultures for the main purpose of
model validation. We will then move on to the construction of our model and
the accompanying simulations, and finally displaying the results of our investi-
gations using the constructed model.
4.1 Minimal media growth
The ability to grow P. falciparum on a nutrient-restricted medium, while still
maintaining a growth rate comparable to that of standard growth conditions was
attempted. If successful, this would allow for a more tractable UPLC analysis
of the amino acid metabolic profile of P. falciparum, as well as the degree to
which the parasite can rely on haemoglobin as a primary source of amino acids.
A range of growth media conditions were used to test the dependence of P.
falciparum on serum-sourced amino acids for growth. Being able to grow para-
sites on a minimal medium that still produces similar growth characteristics as
31
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that of standard media would allow for a much clearer picture of haemoglobin
metabolism and its importance as an amino acid source for biomass production.
It would also allow for a higher resolution of amino acid metabolic profiles ac-
quired from UPLC-UV analysis. Life cycle progression and re-invasion efficiency
was monitored for a spectrum of growth media configurations. Culturing of P.
falciparum in standard RPMI 1640 medium results in approximately four-fold
increases in parasitemia after a 48 hour life cycle (figure 3).
For limited media cultures, life cycle progression is retarded (figure 4) and takes
roughly 72 hours for merozoites to advance through schizogeny and subsequent
re-invasion of daughter merozoites (data not shown). Re-invasion efficiency is
also suspected to be lower in limited media cultures, as once all parasites in each
culture had progressed through schizogeny, parasitemia counts after re-invasions
were 25-40% lower for 5x and I+M culture lines when compared to standard
cultures. This seems to be a case of a fraction of intra-erythrocytic parasites
not progressing to schizogeny and therefore not producing a new generation of
merozoites. In limited media culture lines, some early stage parasites would not
progress to mature trophozoites, instead stalling in what appeared as enlarged
merozoites or compacted early trophozoites. This phenomenon has been noted
in cultures that have been subjected to some form of stress. In this case it is
most likely due to a shortage of specific amino acids required for maturation
of parasites. Ultimately these factors add up to a higher doubling time and
lower specific growth rate for parasites. Under standard culturing conditions we
observe a four-fold increase in parasitemia every two days (˜24 hour doubling
time). What we observe with the limited media cultures however, is a doubling
time of 50.2 hours for ’I+M’ and 67.3 hours for ’5x’ (table 1). Cultures contain-
ing only isoleucine as an exogneous amino acid ’I’ displayed a negative specific
growth rate, indicating additional exogenous amino acid types were required for
P. falciparum to increase in biomass.
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Table 1: Calculated specific growth rates and doubling times for P. falciparum
grown in a variety of media conditions
Culture line Specific growth rate (µ) Doubling time (h-1)
Standard 1 0.0302 23.0
Standard 2 0.0297 23.3




4.2 48 hour sampling of parasite growth
When parasites were inoculated in fresh medium and grown without refreshing
the medium, at the 36 hour timepoint, culture serum appeared to be darken-
ing and life cycle progression appeared sluggish when observed microscopically.
Blood slides would show unhealthy parasites to appear as dark, compact spheres
within erythrocytes (figure 5). Further evidence of stressed parasite growth is
shown in appendix A: figure 1, contrasting the healthy progression of parasites
to schizonts in comparison with the halted growth of stressed parasites. In
follow-up experiments we incorporated a 24 hour media-refresh. This means
that UPLC-determined concentrations for 36 and 48 hour samples will not dis-
play the changes in metabolite concentrations from the 24 hour timepoint, but
rather show the changes in concentrations from effectively “a 0 hour” metabolite
concentration profile. As a result of this, metabolite concentrations recorded for
36 and 48 hour samples were normalised to the concentrations obtained at the
24 hour mark. To accomplish this, we used the following formula to determine
the concentrations for each metabolite expected if refreshing of culture media
did not reset the metabolite concentrations at the 24 hour timepoint:
Concexp = Conc36h + (Conc24h − Conc0h)
In other words, the expected 36 hour concentration for each metabolite we
would observe in a normal culture (Concexp36h), is equal to the sum of the
recorded concentration at the 36 hour timepoint (Conc36h), and the difference
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between concentrations recorded at 24 hours (Conc24h) and that of fresh medium
(Conc0h).
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 4. RESULTS 35
Fig.3 Three independent P. falciparum cultures (Standard 1, Standard 2, Stan-
dard 3) were grown in standard RPMI 1640 and parasitemia counts were
taken at 24 hour intervals. Based on the relative increases in parasitemia
over time a projection of biomass growth was generated.
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Fig.4 Growth rates observed for P. falciparum grown in a variety of lim-
ited media, with 24 hour sampling intervals. Parasites were cultured
in three limited RPMI 1640 media conditions: The suspected core 5
amino acids (isoleucine; glutamine; glutamate; cysteine; methionine)
’Ile,Met,Gln,Glu,Cys’, an isoleucine only line, ’Ile’, and a line containing
isoleucine and methionine ’Ile,Met’.
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Fig.5 Microscope image captured of a blood slide of a P. falciparum culture
undergoing metabolic stress. “A” = healthy ring-stage parasite; “B” =
parasite exhibiting metabolic stress, observed as a solid, compact mass;
“C” = healthy trophozoite-stage parasite.
4.3 UPLC-UV analysis
To test the accuracy of the supplier-stated concentrations for RPMI media,
concentrations of amino acids calculated for RPMI 1640 growth media (based
on information supplied by Sigma-Aldrich) were compared to UPLC analysed
concentrations of prepared RPMI medium (figure 6). Furthermore, controls
of known concentration of the five core amino acids (glu; gln; met; ile; cys)
were analysed (figure 7). These controls would be run along-side experimental
samples.
Six P. falciparum cultures (3 x 9% parasitemia; 3 x 21% parasitemia) were
sampled at 12 hour intervals for 48 hours and immediately flash-frozen in liquid
nitrogen. Additionally, parasitemia and parasite health were monitored micro-
scopically for each sample. The sampling of cultures was initiated when parasites
were entering the late-schizont stage of development to avoid the potential loss of
merozoites yet to invade erythrocytes that could occur if sampling was initiated
during the merozoite stage. Samples from high parasitemia and low parasitemia
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culture lines were submitted to the Central Analytical Facility at Stellenbosch
University, for UPLC-UV analysis (figure 8). Chromatograms from the amino
acid analysis provide a visual display of the amino acid concentrations repre-
sented by the peak heights for amino acids eluting at their respective retention
times. Figure 9 contains the chromatograms of two controls included in the
analysis, five amino acids of known concentration (above) and standard RPMI
1640 (below). Figure 10 provides a visual comparison of the changes in peak
heights over 48 hours for P. falciparum lifecycle. Observed is general accumu-
lation of amino acids over the 48 hour timeframe, such as ornithine, glutamate
and alanine. Amino acids such as arginine and isoleucine are visibly decreased
in concentration by the 48 hour timepoint.
Concentrations of the majority of amino acids were increased by the end-stage
of parasite maturation, barring isoleucine, methionine, arginine, glutamine, cys-
teine and aspartic acid, which decreased. P. falciparum metabolic activity is
known to be highest during the trophozoite stage of development [77]. Our
experimental data reflects this where we see large consumption of glutamine
between the 24-36 hour mark. In line with this we observe a rise in exported
glutamate and alanine. This accounts for the 24 hour timepoint shift by the
parasite from glucose being favoured for the production of TCA-intermediates
to glutaminolysis-derived α-ketoglutarate from glutamine [76]. Along with the
increase in glutamine metabolism from 24-36 hours, we also see a high rate of
arginine depletion from the medium, and a resultant spike in ornithine export.
This is mostly due to the increase in the parasite arginase activity [77]. Parasites
are at a late trophozoite stage at the 36 hour mark, so between 36-48 hours, we
expect to see an increase in the rate of energy metabolism and macromolecular
biosynthesis as parasites enter the process of schizogeny. We observed a linear
consumption of isoleucine throughout the first 36 hours of growth, and then
consumption increased slightly during the late trophozoite stage of growth. In
line with this, we saw a large increase in accumulation of alanine, glutamate and
ornithine for this final 12 hour period of parasite maturation, but also to a lesser
extent, leucine, histidine, glycine, threonine, proline, valine, and phenylalanine
(figure 8).
Arginine metabolism seemed to be the highest of all amino acids, most notably
between the 24-36h time-points, which was reflected closely by ornithine accu-
mulation (figure 11). An interesting observation that after correcting for the 24
hour media refresh, as observed in figure 8, we predict that high parasitemia
cultures of P. falciparum (>10% parasitemia) will deplete exogenous arginine
supply if left to grow in the same medium for longer than 24 hours. Combining
the arginine and ornithine concentrations as a total concentration indicate a
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Fig.6 Concentrations of amino acids, as stated by Sigma-Aldrich (St. Louis,
Missouri, USA), were compared to UPLC-UV analysed samples of stan-
dard culture media. “M” = un-inoculated RPMI 1640 medium; “Calcu-
lated” = millimolar calculated concentrations based on information sup-
plied by Sigma-Aldrich (St. Louis, Missouri, USA); “low0h” = 9% para-
sitemia culture right after inoculation; “high0h”= 21% parasitemia culture
right after inoculation.
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Fig.7 Control samples of known concentration (“Calculated”) were analysed by
UPLC-UV (“Analyzed”) and compared to evaluate the accuracy of UPLC-
UV analysis.
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Fig.9 Integrated chromatograms generated from UPLC-UV analysis of five
amino acids (gln; glu; met; cys; ile) in phosphate buffer (above), and
fresh RPMI 1640 culture medium (below).
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Fig.10 Integrated chromatograms generated from UPLC-UV analysis of amino
acid profiles for timepoint zero (above) and 48 hour endpoint (below) of a
9% parasitemia P. falciparum culture.
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strong favourability towards arginase primarily processing arginine, where the
gradual loss in total concentration (“Low48h”; “High48h”) is most likely at-
tributed to minor conversion of arginine to citrulline by an arginine deiminase
(figure 11).
4.4 Model Construction
The network reconstruction conducted by Plata et al. [89] was used as a starting
point for the construction of a model to investigate P. falciparum growth depen-
dencies in relation to amino acid metabolism. The first step was making sure
all network reconstruction data was successfully imported to allow for model
simulations. In order to recreate the core growth metabolism of the parasite,
we would have to recreate the mass conversion of glucose to lactate observed
in the intra-erythrocytic parasite, in conjunction with the rapid catabolism of
haemoglobin featured in the parasite’s complex amino acid metabolism. The
terms “exchange reaction” and “transport reaction” will appear quite often in
this section. Before explaining our process of model construction we will ex-
plain the difference between these two terms. An exchange reaction represents
the net flux of a metabolite between the model organism and the extracellu-
lar environment, whereas a transport reaction is a reaction responsible for the
transfer of a specific metabolite between different intracellular compartments.
Exchange reactions are thus important indicators of the modeled system’s deci-
sions to import or export a variety of metabolites and the magnitude at which
it occurs.
This would require us to set our solving algorithm to prioritize the digestion
of haemoglobin for amino acid metabolic requirements, while still optimizing
for biomass production. The primary objective functions of the model were
set for optimising biomass production and haemoglobin digestion. A minor
prioritization was also set for glucose uptake to ensure its favouring as a carbon
source. This was done by setting an additional objective function on the glucose
exchange reaction to optimise glucose import. The biomass objective function
was, however, still the primary optimisation and this was maintained by setting
optimisation weighting values of the biomass reaction, haemoglobin reaction,
and glucose exchange reaction to 1.0, -1.0, and 0.01 respectively.
The core function of the model was to prioritise biomass production via the
harvesting of amino acids provided by haemoglobin catabolism and glucose as
the primary carbon source. Any insufficiencies in amino acid supply through
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Fig.11 Concentration shifts for arginine and ornithine over a 48 hour life cycle
of P. falciparum, accounting for a 24 hour media refresh. “Low” = 9%
parasitemia cultures. “High” = 21% parasitemia cultures. “Low48h” and
“High48h” are summed concentrations of arginine and ornithine concen-
trations.
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haemoglobin would then be made available via amino acid exchange reactions
mimicking exogenous amino acid supply. Excess amino acids produced via
haemoglobin degradation would be exported via these same exchange reactions.
In essence, we would be able to predict a metabolic profile of the amino acid
metabolism of P. falciparum in a minimal medium environment, using the the
amino acid exchange reaction fluxes simulated by the model. Some biologi-
cally relevant constraints were added to the model, especially for haemoglobin
digestion rates and P. falciparum growth rates.
In the boundless state of the model, there are no biological constraints on the
model (no maximal or minimal reaction rates have been defined), and one can
see how the model attempts to consume as much glucose as it possibly can, as
this is what the model has been programmed to do (figure 12). Constraints
therefore needed to be applied so that the output fluxes of exchange reactions
representing the core metabolism of the parasite were more in line with what
can be observed in nature. In the following sections each of these constraints
are detailed, and how they were determined.
4.4.1 Some initial calculations
Model flux outputs are represented in the units mmol / gDW / hour and model
simulations would be conducted under the conditions of a 50 mL, 9% parasitemia
culture at 4% haematocrit. Applying any biological constraints would therefore
require conversion to this specific set of conditions.
As seen in figure 12, without defining an acceptable rate of biomass formation
(“B”), the model will produce biomass at a rate that is only constrained by the
rate at which it can acquire the necessary components. Without any constraints
on the exchange reactions providing these building blocks, import fluxes and
export fluxes appear at rates at the maximal and minimal bounds established for
the model. It is thus important to parameterize the model, and establish some
fundamental metabolic rates. We started by determining the specific growth
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ln(B) = µt+ c




A young intra-erythrocytic merozoite has an approximate volume of 5 fem-
tolitres and over a 48 hour life-cycle progresses to a schizont of 70 femtolitres
(14 times increase) [17]. Substituting in these parameters, we can establish a
maximal specific growth rate:
14 = 1e48µ
ln( 141 ) = 48µ
Specific growth rate: µ = ln(14)48 = 0.0550h
−1
This rate of 0.0550h−1 was used to define the maximal amount of biomass that
could be formed per hour in the model.
As the model uses the unit of mmol/gDW/h, we needed to determine the dry
mass of a single parasite, which could then be scaled up to the parameters
established for the model. We calculated the parasite dry weight for a 9%
parasitemia culture in a 50 mL volume. Penkler et al. [87] established that the
intracellular volume of a trophozoite had a volume to protein dry mass ratio
of = 4.67µL.mg−1, which when inverted is = 14.67 = 0.214mg.µL
−1. Assuming




Using 5 fL as the volume of a single merozoite [17], we can calculate the dry
mass of a single merozoite using our established biomass per volume ratio:
5 fL× 0.476× 10−9mg.fL−1 = 2.38× 10−9mg = 2.38× 10−12gDW
The total dry parasite mass in a standard 9% parasitemia can be calculated
using the dry mass of a single merozoite. Our standard cultures consisted of
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growing parasites at 4% haematocrit in 50 mL culture flasks. Therefore 2mL of
this volume is expected to be compact red blood cells. At an average volume
of 90 fL per erythrocyte [73], there will be about 2.22×1010 total red blood cells.
Culture parasitemia is determined as the percentage of infected erythrocytes
of total erythrocytes. Given a 9% parasitemia culture, there will be about
2.00×109 infected red blood cells. Above, the average mass of a single merozoite
was calculated to be 2380 femtograms. Multiplying this mass by the 2.00× 109
infected red blood cells, a total dry mass of 0.00476 g parasites can be estimated
for a 9% parasitemia culture at 4% haematocrit.
The next goal was to estimate the rate of haemoglobin catabolism. In a 48 hour
parasite life-cycle, approximately 75% of haemoglobin is digested by the parasite
[63]. Using an established mass of haemoglobin per red blood cell of 27.2e−12g
[88] and 64458.0 grams per mole as the molecular weight of haemoglobin, a
haemoglobin digestion rate in millimoles per hour can be calculated if the rate
was linear over time.







We can express this rate of haemoglobin digestion as: Hb(t) = Hb(0)− cB0eµt,
where we can calculate our haemoglobin remaining at a given time “Hb(t)” is
equal to our starting haemoglobin in a given erythrocyte “Hb(0)” minus the
haemoglobin digested by the relative amount of parasite biomass calculated for
the given time (“c”).
Using the mass of Hb per erythrocyte as = 27.2e−12g [88], and MWHb =
64458.0 g/mol, we can calculate the moles of Hb per cell as:
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64458 = 4.2× 10
−16moles = 4.2× 10−13mmoles
Therefore, assuming complete Hb consumption for a 48 hour life cycle:
Hb(0) = 4.2× 10−13mmoles
Hb(48) = 0.0mmoles
Using the values at time-points 0 and 48 hours, we can calculate the mmoles of
haemoglobin digested per single intra-erythrocytic parasite over a 48 hour life
cycle:
Hb(48) = Hb(0)− cB0eµ(48) (mmol = mmol − (c)(gDW )(e(h
−1)(h)))
0.0 = 4.2× 10−13 − ((c)(1.28× 10−12)(e0.0550(48)))
1.79× 10−11(c) = 4.2× 10−13 (mmol = (c)(gDW)(e))
c = 2.346× 10−2mmol/gDW (per 48 hour life cycle)
Using a linear rate of haemoglobin consumption over the 48 hour life cycle,
we calculated the mmoles of Hb digested per gram of parasite dry mass per
hour (mmol/gDW/h) by dividing by 48, to give us a haemoglobin digestion rate
of 4.89× 10−4 mmoles/gDW/h.
4.4.2 Applying constraints to the model
While defining haemoglobin catabolism parameters, it was found that the haemoglobin
catabolising reaction in the model produced only half the amino acid con-
stituents of a full human haemoglobin tetramer as a result of incorrect haemoglobin
composition in the model file, as published in [89]. Additionally the stoichiome-
try of haemoglobin erroneously included two extra methionine components. This
was found to be the start codons which are cleaved during post-translational
modification of haemoglobin and were thus deducted from the number of me-
thionines produced per haemoglobin consumed.
The core constraints were applied to the model as calculated above and then
examined model simulations for any remaining fluxes that were extremely high.
It was observed that the model was still finding alternative pathways to obtain
metabolites for growth and energy metabolism. From the extremely high import
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fluxes in figure 13, we can determine the reaction pathways that would need to
be addressed.For the sake of model stability, even a boundless reaction with a
theoretical maximum flux of positive or negative infinity requires an upper and
lower bound to prevent model simulation crashes in the result of flux calcula-
tions to infinity. Upper and lower bounds of 1 000 000 mmol/gDW/h and -1 000
000 mmol/gDW/h were set for all reactions. Therefore, when reaction fluxes
reaching one million mmol/gDW/h are observed, it is understood that the re-
action flux is approaching infinity. This is an un-natural flux calculation, and
is addressed by pathway flux analysis to identify problematic reactions causing
these un-intended flux predictions. It is important to note that the application
of the following constraints mentioned hereafter are implemented for the sake
of model stability and do no affect the amino acid metabolism in the model in
any way. A large portion of the metabolites shown in figure 13 are involved in
the glycolytic pathways of the parasite, so our first strategy was to lock these
metabolites within glycolysis and the TCA cycle by preventing their export out
of the cell or any import of pathway intermediates. This was done by constrain-
ing the exchange reactions for any metabolites involved in glycolysis or the TCA
cycle that displayed a tendency for significant import or export. The import
reactions showing extremely high fluxes (EX akg e, EX ade e, EX dgsn e, and
EX ins e), were addressed initially, as many of the export reactions with ex-
tremely high fluxes were directly linked to the activity of these import reactions
(figure 13). Simulations were conducted again and any new problematic ex-
change fluxes that appeared were addressed. This process was conducted until
natural carbon metabolism was observed, where no intermediates were being
imported or exported unnecessarily (figure 14).
We then addressed any other metabolites that were entering or leaving the cell
at a very high rate. We observed a very high rate of oxygen and water uptake.
This was attributed to the superoxide dismutase and glutathione peroxidase
reactions. The model was set to only take up oxygen and only export carbon
dioxide, and the peroxide exchange reaction was turned off.
The biomass reaction requires a purine source to produce biomass units, which
can be acquired via inosine, adenine or hypoxanthine. However adenosine and
inosine were shown to be potential metabolites for carbon metabolism, so they
were constrained to zero and hypoxanthine was used exclusively.
As it is not a component of haemoglobin, isoleucine import is required for
biomass production and the exchange reaction was set to import only.
Infinite loops can occur during the simulation of network models, whereby a
product of one reaction is used as the substrate of another reaction, however
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Fig.12 Flux distribution output of the boundless model after establishing the
model objective functions for glucose catabolism, haemoglobin catabolism
and biomass production. DIN = deoxyinosine; ADN = adenosine; DGSN
= deoxyguanosine; URA = uracil; GLC = glucose; NH4 = ammonium;
NO3 = nitrate; F6P = fructose-6-phosphate; H2O = water; SUCC =
succinate; PI = inorganic phosphate; O2 = oxygen; AKG = alpha-
ketoglutarate; GSN = guanosine; FUM = fumarate; H2O2 = peroxide;
GAM6P = glucosamine-6-phosphate; H = protons; NO2 = nitrite; CO2
= carbon dioxide; GUA = guanine; DURI = deoxyuridine; HXAN = hy-
poxanthine; SBT = sorbitol; LAC = lactate; DAD = deoxyadenosine.
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Fig.13 After applying the biological constraints to the core exchange reactions
(haemoglobin digestion and biomass production), displayed are the flux
values still above 0.05 mmol/h/gDW in magnitude. ADE = adenine;
INS = inosine; O2S = superoxide anion; CHOL = cholesterol; 4AHMMP
= 4-amino-5-hydroxymethyl-2-pyramidine; THM = thiamine; GLYC =
glycerol; OCDCEA = octadecenoate; XAN = xanthine; INOST = myo-
inositol; MAL = malate; PYR = pyruvate; DIN = deoxyinosine.
the product of the second reaction is the substrate of the first reaction, resulting
in a metabolite being locked into an endless loop. These infinite loops are able
to accumulate the entire pool of a metabolite and break model simulations. To
prevent infinite looping, some reactions were set to either forward/reverse only,
and in some cases turning off reactions completely.
We were still observing fluxes indicating extreme metabolic activity. Lactate
production was at the upper bound of the model while the rate of glycolysis was
occurring at a much lower, acceptable flux. This was initially observed with a
mass import of glutamate and aspartate, and a concomitant export of glutamine
and lactate (figure 14). The amino acid antiporter reaction “AKGMAL” was set
to zero to prevent the looping of malate and α-ketoglutarate. This antiporter
is part of a coupled-transporter known as the malate-aspartate (M-A) shuttle.
The second transporter coupled in this M-A shuttle is a glutamate-aspartate
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Fig.14 Exchange fluxes above 0.05 mmol/h/gDW had been addressed and the
model was updated. Displayed in this figure are the unnaturally high
exchange fluxes still simulated by the model. From this we addressed
infinite loops, identified initially from the large flux outputs for glutamate,
aspartate, and glutamine. AC = acetate; HDCA = hexadecanoate; CYTD
= cytidine.
transporter. In our model, glutamate and aspartate were being mass-imported
for the downstream transamination of alanine for pyruvate production, which
would then be used for biomass production.
4.4.3 Model simulations
Initial simulations of our curated model proved to successfully make use of
glucose as a primary carbon source, and haemoglobin as the primary amino
acid source, to produce biomass, while importing any lacking (glutamine) or
missing (isoleucine) biomass components. There were however some unexpected
fluxes. The model seemed to highly favour a selection of amino acids for biomass
generation, in order of rank: glutamine, asparagine, aspartate, glutamate. The
asparagine and aspartate utilisation is odd as no literature supports this notion.
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As the model would import as much glutamine as it could for growth, we had
to establish an upper bound constraint on the glutamine exchange reaction
(“EX gln L e ”).
Determining a maximum bound for exogenous glutamine uptake:
In standard RPMI medium, glutamine exists in concentration: 0.3 g/L. For
standard 24 hour growth before medium is refreshed, 21% parasitemia cultures
will grow healthily, and are assumed to not deplete exogenous glutamine. There-
fore, in 24 hours, at most we would expect 0.3 g/L/24h for a 21% parasitemia
culture, resulting in: 1.25× 10−2 g/L/h. Using MWgln = 146.14 g/mol, we get
8.55 × 10−5 mol/l/h. Model fluxes are in “mmol/gDW/h”, therefore we scale
the gDW of a 21% parasitemia culture to per 1 gDW:
gDW of parasite in a 21% parasitemia culture: 1.11× 10−2 (calculated above)
Scaling to 1 gDW we get: 7.698 mmol/l/gDW/h of glutamine
Cultures are grown in 50 mL flasks, and the current flux is per litre, so con-
version to 50mL volume yields: 0.385 mmol/gDW/h for a 50 mL volume (as
used for experimental data). Thus, in a 9% parasitemia culture, the maximum
possible uptake rate of glutamine could be 0.385 mmol/gDW/h for a 50 ml vol-
ume culture, and was set as our upper bound for exogenous glutamine import.
From literature findings, and confirmation from our own experimentation, that
parasite arginase plays a large role in free arginine being converted to ornithine,
the arginase reaction flux was clamped on 3.30× 10−1 mmol / gDW / h, based
on arginase activity observed by Olszewski et al. [77]. In addition, the ornithine
aminotransferase reaction was constrained to zero to prevent ornithine recycling
back into the system.
4.5 Preliminary predictions of haemoglobin
supply and biomass demand
Prior to conducting model simulations of the production of parasite biomass and
the concomitant catabolism of host haemoglobin, a thought experiment would
be to theoretically predict how much biomass could be formed per haemoglobin
molecule, based on the compositions of biomass and haemoglobin as present
in the model. This would also provide a strong motivation for the necessity
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of a model based on a complicated network for amino acid metabolism in P.
falciparum.
In the model there is a reaction responsible for the digestion of haemoglobin
“HMGLB”, supplying freed amino acids to the parasite for biomass production.
The biomass objective function (BOF), named in the model as “biomass”, is a
manually created reaction that harvests a large variety of components created by
the metabolic network necessary to create a“unit”of biomass. As this BOF is an
artificial reaction, we represent biomass production as the rate of production of
these units. By comparing the compositions of haemoglobin molecules and these
units of biomass produced by the model, we can make preliminary predictions
on which amino acids will likely be most limiting by haemoglobin catabolism
(assuming no interconversions of amino acids occur). Further, assuming no
availability of exogenous amino acids (besides isoleucine), we can predict how
many units of biomass can be produced by the biomass reaction for the total
haemoglobin provided within a single red blood cell before specific amino acid
supply would start to run out.
The number of haemoglobin molecules required to generate 10 000 units of
biomass was calculated (calculations based on 10 000 units for aesthetic appeal),
and on the compositions of haemoglobin and biomass (table 2). Tryptophan was
calculated to be the shortest in supply, requiring 350 haemoglobin molecules to
produce enough tryptophan for the production of 10 000 units of biomass. This
is followed by asparagine, which requires 313 haemoglobin molecules.
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Table 2: Comparing biomass composition versus haemoglobin composition to
illustrate the basic supply and demand of amino acids in the modeled
system. “AA” = amino acid, “AA/Hb” = amino acid per haemoglobin
molecule, “AA/10 000 biomass” = number of each amino acid required
to produce 10 000 units of biomass, “Hb/10 000 biomass” = haemoglobin
molecules required to supply enough of a specified amino acid to produce
10 000 units of biomass.
AA AA/Hb AA/10 000 biomass Hb/10 000 biomass
ala 72 1364 19
arg 12 1349 113
asn 20 6245 313
asp 30 2994 100
cys 6 674 113
gln 8 1353 170
glu 24 3505 147
gly 40 1827 46
his 28 1063 39
iso 0 3566 N/A
leu 72 3405 48
lys 44 5124 117
met 6 1019 170
phe 30 1823 61
pro 28 1085 39
ser 32 3055 96
thr 32 2045 64
trp 6 2095 350
tyr 12 1379 115
val 62 2030 33
Using the average amount of haemoglobin in an erythrocyte = 4.2 × 10−13
mmoles (calculated previously), and assuming 75% of haemoglobin is digested
during a 48 hour life-cycle of an intra-erythrocytic P. falciparum, we can use
Avogadro’s constant to calculate the number of molecules of haemoglobin present
within a red blood cell:
75% of haemoglobin consumed = 3.15× 10−13 mmoles
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Avogadro’s constant = 6.022× 1023 molecules in one mole of substance
We can estimate there are 1.9 × 108 molecules of haemoglobin digested in a
48 hour life-cycle by an intra-erythrocytic parasite.
Taking the number of digested haemoglobin molecules into account, the max-
imum units of biomass that can be generated using the released amino acid
molecules can be calculated (table 3).
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Table 3: Predicting the amount of biomass units that can be formed by the
biomass objective function solely using amino acids supplied via the catabolism
of haemoglobin within a single erythrocyte. “AA” = amino acid, “AA/Hb”
= amino acid per haemoglobin molecule, “AA/total erythrocyte Hb” =
Number of molecules of each amino acid for the total haemoglobin found
in an average erythrocyte, “Biomass/erythrocyte” = The total potential
biomass units produced using the haemoglobin within a single erythrocyte.
AA AA/Hb AA/total erythrocyte Hb Biomass/erythrocyte
ala 72 1.4× 1010 1.00× 1011
arg 12 2.3× 109 1.69× 1010
asn 20 3.8× 109 6.08× 109
asp 30 5.7× 109 1.90× 1010
cys 6 1.1× 109 1.69× 1010
gln 8 1.5× 109 1.12× 1010
glu 24 4.6× 109 1.30× 1010
gly 40 7.6× 109 4.16× 1010
his 28 5.3× 109 5.00× 1010
iso 0 N/A N/A
leu 72 1.4× 109 4.02× 1010
lys 44 8.4× 109 1.63× 1010
met 6 1.1× 109 1.12× 1010
phe 30 5.7× 109 3.13× 1010
pro 28 5.3× 109 4.90× 1010
ser 32 6.1× 109 1.99× 1010
thr 32 6.1× 109 2.97× 1010
trp 6 1.1× 109 5.44× 109
tyr 12 2.3× 109 1.65× 1010
val 62 1.2× 1010 5.80× 1010
From table 2 and table 3 we can predict that modeled simulations will most
likely indicate (in order of demand): tryptophan, asparagine, methionine,
glutamine, glutamate, lysine, arginine, and cysteine, as the amino acids
with the highest dependency on exogenous supply to allow for optimal
biomass production. Using our model based on the complex metabolic
network of amino acid metabolism for intra-erythrocytic P. falciparum we
hope to provide further insights.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 4. RESULTS 59
4.6 Network reconstruction simulations
4.6.1 Overview of P. falciparum flux profile, as
simulated by the network reconstruction
Once we had applied all our constraints to the network, our simulations started
to predict a flux distribution that was more in line with literature expectations.
The largest fluxes through the modeled system are presented in figure 15, dis-
playing vast conversion of glucose to lactate, indicating a functional glycolysis
system. There is also a build up of urea and ammonia that is successfully
exported by the parasite. Amino acid metabolism comprises a large part of
metabolism in Plasmodia. Many transamination reactions occur in the para-
site. For example, in figure 15 it can also be seen how exogenous glutamine
has a large import flux and glutamate is exported out the cell. Glutamine
can be processed by the parasite to α-ketoglutarate, by a set of transamination
reactions, leading to the production of ammonia and urea.
In culturing conditions, exogenous arginine is taken up by the parasite at a
high rate and converted to ornithine (arginine + H2O  ornithine + urea),
before exporting out of the system. We manually clamped the arginase reaction
flux to the rate of ornithine accumulation we determined experimentally (figure
11) of 0.330mmol/h/gDW . From this added constraint we observed how argi-
nine import and ornithine export increased accordingly. We had set the upper
limit of our BOF to 0.0550 h-1and simulations displayed that maximal biomass
formation rate was achieved.
4.6.2 Model-predicted flux profile for an asynchronous
P. falciparum culture compared to an
experimental data set
To test the accuracy of our model simulations we compared our simulation
data to a set of experimental data obtained via UPLC-UV analysis of time-
point samples obtained from asynchronous P. falciparum cultures grown at 9%
parasitemia.
Experimental fluxes were calculated for each of the amino acids from the UPLC-
UV observed changes in amino acid concentrations over a 48 hour period and
converted from millimolar to mmol/h units for a 50mL volume to match the
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Fig.15 Overview of major fluxes predicted by the modeled system for P. fal-
ciparum. Negative values indicate a net import flux and positive values
indicate a net export flux. OMASS = Biomass; ORN = ornithine; UREA
= urea.
units used in the model. Additionally calculated fluxes were converted from
parasite dry weight calculated for a 9% culture (4.76 × 10−3 gDW) to 1 gDW,
as used in the model (mmol/h/gDW).
Qualitatively, fluxes predicted by the model compared well with our experimen-
tal data (figure 16). Both systems displayed a large favourability for exoge-
nous glutamine as a primary amino acid source, with a resultant net export
of glutamate and alanine, produced during glutaminolysis. The model indi-
cated a slight over-utilization of glutamine as a result of us manually clamp-
ing the glutamine import flux at the maximum possible rate we could ex-
pect (0.385 mmoles/gDW/h). Upon closer inspection, in our experimental
data we see that the net import flux of glutamine is substantially higher than
the glutamate export flux. In the model, however, the glutamate export flux
(0.374 mmoles/gDW/h) is almost as high as the import flux of glutamine (0.385
mmoles/gDW/h). Paired with this, in our simulations we see a smaller export
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flux for alanine. In the process of glutaminolysis, glutamine is partially deami-
nated to glutamate. Thereafter three possible pathways are possible. Glutamate
can either be further deaminated to produce α-ketoglutarate and ammonium,
transfer the ammonium group to pyruvate to form alanine (transamination),
or transfer the ammonium group to oxaloacetate to form aspartate (transam-
ination). Our simulations indicate that perhaps glutamate is not being fully
utilised in this glutaminolysis pathway of the model. Comparing model to ex-
perimental data, we see a lower glutamate utilisation and as a result a smaller
export flux of alanine by the model. This could also be a possible reason for the
unexpected import fluxes of exogenous aspartate and asparagine we see in our
model.
Arginine is also largely converted to ornithine by arginase in experimental cul-
tures as well as computational simulations. Ornithine export in the model was
clamped to the flux we determined experimentally. Model simulations showed
a 96% conversion of arginine to ornithine in the model. In experimental data
that is slightly less and likely a result of an arginine deiminase converting some
of the arginine into citrulline.
The amino acid flux distributions in figure 2 of Appendix C are preliminary
simulations of amino acid flux distributions. Later in the development of the
model, more accurate flux distributions can be observed once the correct con-
straints and boundary flux values were introduced (for biomass formation rate,
haemoglobin digestion rate, and glucose consumption rate).
4.6.3 Investigation of model dependencies on various
exogenous amino acids
Exchange reactions responsible for the import and export of metabolites between
the parasite and cytosol of the host erythrocyte were systematically switched off
and the effect thereof on parasite growth characteristics were examined. Remov-
ing exogenous isoleucine uptake prevented any biomass formation and energy
demand by the parasite reflected this. When glutamine import was turned off
only a slightly higher lactate production was observed, indicating that while
glutamine is a desired source of amino acid, the model is able to make use of
the various other amino acids in its absence, but causing a small increase in
lactate production (Table 4). The increased transaminations occurring in the
absence of glutamine increase the energetic demand of the parasite to produce
biomass in the model. Analysis of upstream pathway fluxes revealed this in-
creased lactate export flux to be as a result of glycerol being imported by the
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cell to use as a carbon source. As a result of the additional reactions occurring
in the absence of glutamine, the maximum glucose import rate was no longer
sufficient to provide enough fuel for glycolysis.
The individual removal of exogenous arginine, methionine and tyrosine import
resulted in lowered biomass production rates, indicating haemoglobin is not able
to provide sufficient amounts of these amino acids, and that exogenous supply
is necessary to sustain optimal growth by the parasite. The removal of ex-
ogenous proline and glutamate had no effect on parasite growth characteristics
as the model suggests these amino acids are provided in sufficient quantity by
catabolism of host haemoglobin (indicated by a net export of glutamate and
proline in figure 16). When we simulated parasite growth on only haemoglobin
and exogenous isoleucine, biomass production rates dropped to 52% of optimal
rate. This is the same production rate observed as in the “no methionine” sim-
ulation, indicating that the absence of methionine alone is restricting growth
rates to 52% regardless of availability of other amino acids. Adding exoge-
nous methionine supply to simulated media containing only isoleucine led to
a biomass production rate of 76%. However, when we supplied the other two
exogenous amino acids indicated as necessary for optimal parasite growth, argi-
nine and tyrosine, there was no further increase in biomass production rates.
These model findings suggest that there is one or more amino acids, in addition
to those currently mentioned in literature, required by Plasmodium falciparum
to achieve maximal growth. Additionally, in comparison to the growth rates we
measured for limited media cultures, we saw that restricting cultures to exoge-
nous isoleucine and methionine only, we could achieve growth rates around 48%
of optimal rate (table 1).
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Table 4: Absence of exogenous amino acids and their effect on parasite growth
(expressed as a percentage of standard growth simulations)
Model restriction Hb catabolism Glucose cons. Lactate prod. Biomass prod.
Standard growth 100.00 100.00 100.00 100.00
No isoleucine 100.00 0.03 0.42 0
No glutamine 100.00 100.00 113.97 100.00
No arginine 100.00 78.66 78.90 78.72
No glutamate 100.00 100.00 100.00 100.00
No methionine 100.00 52.05 52.33 52.08
No tyrosine 100.00 77.05 77.26 77.16
No proline 100.00 100.00 100.00 100.00
Only isoleucine 100.00 52.96 52.88 52.08
Only ile and met 100.00 78.45 79.18 76.12
Ile, met, tyr, arg 100.00 78.45 79.18 76.12
4.6.4 Model simulation of atovaquone activity
As atovaquone acts to restrict the activity of mitochondrial enzyme, dihydrooro-
tate dehydrogenase, the activity of atovaquone can be simulated by applying
constraints to the reaction in the model representing dihydroorotate dehydro-
genase, named ’DHORD2 mt’. ’DHORD2 mt’ has a normal flux of 0.0128
mmol/gDW/h when simulating standard growth conditions. Figure 18 illus-
trates the uniform decrease in biomass production as we simulate the effect of
increasing atovaquone concentration. Model predictions were compared to a
dose-response curve determined by Srivastava et al. [105] (figure 17) and ob-
serve a similar trend in activity. Srivastava et al. [105] showed that increasing
concentrations of atovaquone would cause an increasing inhibition of respira-
tion in P. falciparum. The rate of respiration in these parasites can be directly
correlated to their rate of biomass production. By simulating the action of ato-
vaquone to inhibit the activity of DHODH in the model, a linear correlation
between the percentage inhibition of DHODH and the percent of optimal rate
of biomass formation displays how the degree of functionality of the DHODH
enzyme directly affects the capacity of P. falciparum to generate biomass.
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Fig.16 Model-predicted amino acid exchange fluxes obtained in comparison
with fluxes calculated from data obtained from UPLC-UV analysed par-
asite culture growth. Fluxes for both sets of data are calculated based
on a 9% parasitemia culture in a 50ml culture of standard RPMI at 4%
haematocrit.
Stellenbosch University  https://scholar.sun.ac.za
CHAPTER 4. RESULTS 65
Fig.17 Dose-response curve of atovaquone effect on Plasmodium falciparum












































Fig.18 Model simulations show that constraining DHODH activity reduces the
ability of Plasmodium falciparum to generate biomass
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Discussion
Network reconstructions are an ideal approach to capture large, intricate bio-
chemical networks within a computational model. In this study we investigated
the dependence of P. falciparum on exogenous amino acid supply in relation to
haemoglobin-derived amino acids. Plasmodia have a very limited capacity for
de novo amino acid biosynthesis, by aerobic CO2 fixation and glucose dissimi-
lation. This limited capacity for synthesis has been shown to not be primarily
directed towards amino acid formation for Plasmodial protein synthesis, but
rather for the replenishment of TCA-cycle intermediates [99]. Plasmodia, in-
stead depend on the catabolism of host haemoglobin housed within erythrocytes,
and free extracellular amino acid in the host’s blood stream. Along with this,
Plasmodia have developed a complex transamination system involved in a vari-
ety of metabolic processes [77, 12, 118]. Genome-scale network reconstruction-
based modeling would therefore be a suitable approach for modeling amino acid
metabolism of P. falciparum. Using a network reconstruction created by Plata et
al. [89], we were able to create a functional model of P. falciparum metabolism.
This model was able to reproduce the mass conversion of glucose to lactate (as
observed experimentally), rapidly catabolise host haemoglobin and scavenge the
freed amino acids, as well as those available extracellularly. When exposed to
unfavourable conditions the model was able to adapt and find alternative solu-
tions to try achieve optimal biomass production rates. Limiting the availability
of extracellular amino acids caused the model to make use of transamination
reactions to produce the missing amino acids required for biomass production.
To validate the findings of the model, amino acid analysis was conducted on P.
falciparum cultures grown for a full 48 hour life-cycle and fluxes obtained from
this data were compared to the outputs of model simulations (figure 16). We also
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displayed the ability of the model to mimic the effects of an active compound
(atovaquone) in a popular antimalarial drug on the growth of P. falciparum.
Divo et al. [16] was able to achieve almost 90% of standard growth in a limited
medium containing only 7 amino acids (isoleucine, methionine, cysteine, glu-
tamine, glutamate, tyrosine, proline). Liu et al. [59] observed 86% of standard
growth, showing at least a 1.8-fold increase in parasitemia over a single life cycle,
using a growth medium supplemented with isoleucine as the sole-added amino
acid. Based on these findings, we attempted to reproduce this high level of
growth in amino-acid-limited media. Our model simulations were able to verify
that we could achieve close to 80% of optimal biomass formation rates (table 4).
Experimentally we were not as successful. When only adding isoleucine to an
amino-acid-free custom RPMI culture medium, parasites were not able to grow
well and we saw a net decrease in parasitemia over time. When adding both
isoleucine and methionine, growth improved to about 50% of standard culturing
conditions. The same was observed when adding the “core” 5 amino acids (ile;
met; gln; glu; cys). This slower growth was largely due to sluggish progression
of parasites through their life-cycle. In standard culturing, merozoites will tran-
sition to mature schizonts within 48 hours. However, in limited media cultures,
parasites would take more than 72 hours to complete a life-cycle. Microscop-
ically, it was observed that a large portion of parasites in limited media were
undergoing metabolic stress, where intra-erythrocytic parasites would appear
as solid, compact masses within a red blood cell (figure 5). Liu et al. [58] ob-
served this same slower life-cycle progression in limited media. It is suspected
that re-invasion efficiency and development of newly invading merozoites are
significantly hampered due to a lack of specific amino acids that might be vital
for parasite development. It is possible that P. falciparum we used in limited
media experiments might have adapted over time to favour exogenous amino
acids for growth over those made available during haemoglobin degradation. In
future experimentation multiple strains should be considered for limited media
culturing. It would also be recommended to reproduce the results obtained by
Divo et al. [16] with his 7 amino acid limited medium.
In our theoretical calculations for specific growth rate, based on data presented
by du Toit et al. [17], we calculated a maximal specific growth rate for P.
falciparum of 0.0550 h−1 to be used in our model. However, in our standard
cultures we observe less than 50% of that rate (table 1). This is primarily as a
result of the specific growth rate used in the model to only represent the rate of
growth for a single life cycle. In a system of multi-generational growth, such as
continuous in vitro culturing there are a number of additional factors affecting
the specific growth rate. Our theoretical specific growth does not account for
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factors such as the time from red blood cell rupture and the accompanying
release of daughter merozoites to the resultant re-invasion. Daughter merozoites
also do not invade with a 100% re-invasion-to-schizogeny efficiency and as a
result a portion of released new progeny will not reach schizogeny and release
daughter merozoites of their own. Perhaps even more importantly, the volume
increase from a merozoite to a schizont is by no means a perfect correlation to
the increase in biomass, and the volume occupied by such a schizont divided
by the volume of a merozoite does not accurately represent the number of new
merozoites that will re-invade host erythrocytes. If this were the case, each
schizont would result in ˜31 newly infected red blood cells, but in literature
there is a reported average of 16-18 merozoites released per schizont [28], almost
50% less than the 31 merozoites we might otherwise presume just on the volume
increase in a given life cycle.
There were some interesting findings from data obtained from amino acid anal-
ysis of 48 hour time-course samples of P. falciparum cultures. Most notably
was the rapid depletion of arginine from the culture medium, accompanied by
a large accumulation of ornithine (figure 11). In a 9% parasitemia culture it is
predicted that arginine would be depleted after 48 hours of growth in standard
RPMI 1640 medium. This is not a significant issue in standard practice, as
culture medium is refreshed every 24 hours. However, in 21% parasitemia cul-
tures, arginine is predicted to be depleted after about 30 hours of growth in the
same medium (figure 8). Previous studies have concluded that arginine is not
required for optimal growth, suggesting that sufficient quantities are obtained
from haemoglobin digestion [59]. Olszewski et al. [77] also showed that the
mass-conversion of arginine to ornithine is not for the use of ornithine as a sub-
strate either, as arginase knockout strains were able to obtain enough ornithine
from the plasma or activity of the host arginase. Instead they hypothesize
that the parasite depletes the host arginine pool to prevent nitric oxide gener-
ation from arginine, suppressing the host immune response. Additionally the
large amount of ornithine produced may compete with arginine for transporter-
mediated uptake into macrophages. Also observed is a notable consumption
of glutamine and resultant build up of glutamate and alanine, which can be
attributed to the switch in parasite metabolism during the trophozoite-stage to
glutamine metabolism as a source of α-ketoglutarate for use in the TCA-cycle.
A small consumption of isoleucine and methionine were also noted.
Some initial calculations were conducted to predict which of the amino acids
supplied by haemoglobin catabolism would be in short supply for biomass pro-
duction in the model. From these calculations it was determined that trypto-
phan, asparagine, methionine, glutamine and glutamate were the top five amino
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acids suspected to require exogenous supply (along with isoleucine, which does
not occur in haemoglobin) for the optimal production of biomass by the model.
Once we had produced an optimized model to simulate parasite metabolism,
we could validate our calculated predictions on amino acid supply and demand.
As expected we saw a demand on exogenous sources of glutamine, methionine
and asparagine. However, the amino acid predicted to have the highest need
for an exogenous supply, tryptophan, showed no need for import of extracellu-
lar supply. Investigation into the reaction network of the model showed that
tryptophan was exclusively used as a building block in biomass formation. This
finding is significant in showing that for the most part haemoglobin should be
able to provide enough building blocks for biomass formation. The demand of
other metabolic processes have a large impact on amino acid demand. Glu-
taminolysis is an example of this, whereby glutamine demand is increased as
a result of glutamine additionally being converted to α-ketoglutarate. Simula-
tions also indicated there was no demand for glutamate import. In fact, the
model showed a net export of glutamate, further re-enforcing the belief that
reactions other than the biomass producing reaction play a large role in amino
acid metabolism.
The primary objective of our research was to investigate amino acid metabolism
in intra-erythrocytic Plasmodium falciparum. To address this objective, we
made use of computational modeling to simulate the metabolism of the parasite,
and then validate the results of our model simulations with experimental data.
In the first chapter we stated four key research questions we would attempt to
answer:
1. Is the model able to reproduce experimental observations in terms of amino
acid incorporation into biomass and amino acid export, using haemoglobin
catabolism as a primary source, and extracellular amino acid scavenging
to make up for any deficits?
2. Can the findings of Liu et al. [59] that Plasmodium falciparum is able to
grow in culture medium containing isoleucine as the only supplemented
amino acid be reproduced?
3. Can a steady-state flux distribution for the model system that is realistic
to what we can observe in nature be identified?
4. From the flux distribution outputs, can any key reactions or metabolites
that could be investigated further as potential drug targets be identified?
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Using a genome-scale network reconstruction of P. falciparum and performing
flux-balance analysis we were able to reproduce experimentally observed fluxes
with good accuracy and display some of the key dependencies of the parasite on
exogenous amino acid supply for optimal growth.The model successfully used
haemoglobin catabolism as a primary source of amino acids for biomass for-
mation and obtained any deficits from extracellular scavenging. Any excess
amino acids were successfully exported from the system. Further, we were able
to simulate the findings of Liu et al. that P. falciparum is able to grow on
nutrient-restricted media at almost 80% of maximal biomass formation rates
[59]. We were, however, not able to identify any novel metabolic targets for
drug development.
Overall the model has provided some interesting insights into the amino acid
metabolism of Plasmodium falciparum. The model has indicated that certain
amino acids such as glutamine, are not vital for the generation of biomass,
however, are more energetically favourable options for growth. Experimental
studies [16] have also indicated a core 7 amino acids (isoleucine, methionine,
cysteine, glutamine, glutamate, tyrosine, proline) required for the optimal rates
of biomass formation, where the model reaffirms this finding in the case of
isoleucine, methionine, tyrosine and arginine. However our model indicates that
the absence of exogenous glutamine, glutamate and proline to not hamper opti-
mal biomass formation. Adding to this, with the four amino acids indicated to
be vital to optimal biomass formation only a 76% of optimal rate was simulated
by the model. This perhaps indicates the necessity for another, unsuspected
amino acid, or perhaps even combination of amino acids to actually reach opti-
mal biomass formation rate (table 4).
Future improvements to the model will allow for more biologically accurate sim-
ulations, and a wider range of applications. Attaining a more accurate molecu-
lar representation of Plasmodium biomass for the creation of biomass objective
functions will create a more realistic picture of metabolic requirements for para-
site growth such as the discrepancies we observed when comparing model versus
experimental amino acid exchange fluxes in figure 16. The addition of more bi-
ologically relevant constraints to reaction fluxes in the model, such as transam-
ination reactions will vastly aid in the understanding of these complex reaction
dynamics. Only partial success was achieved with minimal media culturing.
Testing multiple parasite strains and media conditions are considerations that
should be made when expanding on this work.
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APPENDIX A. MICROSCOPE BLOOD SLIDES SHOWINGUNHEALTHY INTRAERYTHROCYTIC P. FALCIPARUM PARASITESA-3
Fig.1 Microscope blood slides of limited media cultures where stressed parasite
phenotypes were observed. In isoleucine-only supplemented media, within 48
hours of parasite culturing (top and middle) the majority of parasite phenotypes
would present as small, dark
”
compact masses that would persist over time
and culture growth would stall. Compared to the growth of isoleucine- and
methionine-supplemented media cultures, where growth conditions are more
favourable for the parasite, it can be observed that there are fewer stressed
parasites and a greater progression from rings to schizonts (bottom).
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Appendix B
Model constraints
Note: The term “blim” is representative of the minimal/maximal extreme for
a bound (1× 106 mmol/gDW/h, effectively indicating boundless in a way that
does not break the model.
’EX gln L e ’: [-0.385,blim],
’EX hb’: [-4.89e-4, 0],
’biomass’: [0, 0.0550],
’EX ile L e ’: [-blim,0],
’EX glc e ’: [-blim,0],
’EX ins e ’: [0,0],
’EX adn e ’: [0,0],
’EX h2o2 e ’: [0,0],
’EX dgsn e ’: [0,0],
’EX din e ’: [0,0],
’EX nicotinamide2’: [0,0],
B-1
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APPENDIX B. MODEL CONSTRAINTS B-2
’EX gua e ’: [0,0],
’EX ade e ’: [0,0],
’EX inost e ’: [0,0],
’EX fum e ’: [0,blim],
’EX ura e ’: [0,0],
’EX fru e ’: [0,0],
’EX akg e ’: [0,0],
’EX o2 e ’: [-blim,0],
’EX co2 e ’: [0,blim],
’EX f6p e ’: [0,0],
’EX g6p e ’: [0,0],
’EX man e ’: [0,0],
’EX mal L e ’: [0,0],
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Appendix C
Publication
The paper in this Appendix has been accepted for publication in the Biochemical
Society Transactions journal. Contributions made to this paper include the
sections on “Genome-scale network analysis of metabolism” and “Plasmodium
biomass production from haemoglobin”, as well as the accompanying graphics
in figure 2.
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Abstract
We propose a hierarchical modelling approach to construct models for disease states at the whole-body
level. Such models can simulate effects of drug-induced inhibition of reaction steps on the whole-body
physiology. We illustrate the approach for glucose metabolism in malaria patients, by merging two detailed
kinetic models for glucose metabolism in the parasite Plasmodium falciparum and the human red blood
cell with a coarse-grained model for whole-body glucose metabolism. In addition we use a genome-scale
metabolic model for the parasite to predict amino acid production profiles by the malaria parasite that can
be used as a complex biomarker.
Multi-scale hierarchical modelling of
disease states
Diseases manifest as phenotypic changes in whole-body
physiology that are experienced as illness and can be caused
by external factors (e.g. infectious diseases caused by bacteria)
or by internal dysfunction (e.g. type II diabetes, cancer).
Medical treatment of a disease can be in the form of
medication, such as a pharmaceutical drug that affects specific
reactions in target cells. In the case of a so-called ‘magic
bullet’ drug, displaying complete specificity and complete
inhibition of an essential reaction in a parasite or diseased
cell, the outcome of the drug effect is direct and simple to
predict and no detailed analysis is required. However, most
drugs affect more than one reaction step, do not lead to
complete inhibition and have side effects [1]. The response
to such a drug is more complicated and a quantitative analysis
of the combined effects on the whole-body physiology is
necessary to evaluate the treatment. Analysis of whole-body
responses to partial inhibition of one or more reaction steps
is challenging; typically, mathematical models at the whole-
body level are not fine-grained and do not include individual
chemical reaction steps. We propose a hierarchical approach
where parts of a system are resolved with sufficient detail to
analyse drug effects at the individual reaction step, whereas
for other parts of the system coarse-grained models are used.
This approach is illustrated with a multi-scale hierarchical
model for glucose metabolism in malaria patients (Figure 1).
Key words: glucose metabolism, malaria, multi-scale hierarchical model, Plasmodium
falciparum.
1 To whom correspondence should be addressed (email jls@sun.ac.za).
From diagnosis to drug
Medical treatment usually starts with a diagnosis and
classification of a disease. Typically these are initially made
on the basis of simple phenotypic descriptions. Relating these
symptoms to a mechanistic interpretation of the disease is not
a trivial task and will involve a systems based approach [2],
especially when multiple molecular aetiologies with patient-
dependent contributions are involved. Biomarkers play an
important role in such a diagnosis and are likely to be found
at the metabolomics level [3]. A mechanistic, systems level
interpretation of a disease could point to multiple drug
targets, moving away from the single drug single target
paradigm [4]. Such systems approaches to pharmacology
[5] and toxicology [6] could lead to more effective drug
development strategies [7].
Genome-scale network analysis of
metabolism
Metabolomics and metabolic modelling are important tools in
following and predicting disease progress and understanding
drug efficacy and mode of action [3,8]. In the last decade,
enormous progress has been made in the genome-scale
analysis of metabolic networks for a large number of
species ranging from bacteria (e.g. E. coli [9]), to eukaryotes
(e.g. S. cerevisiae [10]) to humans [11,12] and includes
important human pathogens (e.g. Haemophilus influenzae
[13], Mycobacterium tuberculosis [14] and Plasmodium
falciparum [15–18]). These networks are very large, up to
several thousands of reactions and the analyses are restricted
to topological and constraint based modelling techniques,
Biochem. Soc. Trans. (2015) 43, 1157–1163; doi:10.1042/BST20150145 C©2015 Authors; published by Portland Press Limited
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Figure 1 Hierarchical multi-scale model for malaria patients
The whole-body model consists of several modules at the organ level, each described with input-output functions. The red
blood cell compartment is modelled at the cellular and detailed metabolic level, including P. falciparum metabolism.
such as flux balance analysis [19,20]. Such models have
been very useful for calculating metabolic phenotypes [21],
such as the prediction of changes in metabolite biomarkers
for inborn errors of metabolism [12] or, for instance, in
analysing medium composition requirements for bacterial
growth [22]. The models are typically analysed for steady
state conditions and optimization criteria (e.g. growth rate)
are used to minimize the solution space. Choosing suitable
constraints on exchange reactions, biomass composition and
maintenance reactions can have important effects on model
predictions and should be done carefully.
Why study metabolism in malaria
patients?
Malaria is a dreaded disease that is widespread across tropical
and sub-tropical regions and responsible for the death of
between 500000 and 1000000 people per year, mostly children
in sub-Saharan countries. One might not immediately think
of malaria as a metabolic disease; the classic symptom of
48-h cyclical fever attacks and diagnosis via blood smears has
no relation to metabolism. However, the key-diagnostics for
poor chances of survival, lactic acidosis and hypoglycaemia
[23] are clearly linked to metabolism. In addition, in malaria
patients, blood concentrations of glycerol [24] and alanine
are increased and arginine concentration is decreased [25],
indicating more general metabolic changes [26].
To what extent can these metabolic changes be related
to metabolic activity of the parasite? Plasmodium cannot
synthesize its own amino acids and is dependent on the
host’s haemoglobin for protein biosynthesis and on the host’s
glucose for its free energy production. As such, the metabolic
activity of the parasite has a direct effect on the host, but, in
addition, the parasites cause indirect damage by lysis of red
C©2015 Authors; published by Portland Press Limited
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blood cells and sequestration of parasitized red blood cells in
the vasculature leading to reduced blood perfusion [27].
Although the pathophysiology used to be attributed to two
main syndromes, cerebral malaria and severe anaemia malaria,
it has become clear that severe malaria is complicated and
involves several syndromes [27–29]. Ultimately, the goal is to
delineate the individual contributions of these syndromes to
the pathophysiology of malaria. Such an analysis would point
at the best points of intervention to relieve the burden of the
disease. In an attempt to estimate the direct contribution of
Plasmodium activity we set out to analyse its amino acid and
carbohydrate metabolism.
Plasmodium biomass production from
haemoglobin
The genome of P. falciparum was sequenced in 2002
and several genome-scale metabolic maps have been
reconstructed [30]. Plasmodium is severely limited in its
biosynthetic reactions and is largely dependent on the host’s
supply of amino acids for protein synthesis, for which the
parasite degrades almost all haemoglobin in the red blood
cell during its 48-h growth cycle. The specific condition
of Plasmodium growing in the red blood cell and using
the available haemoglobin for protein synthesis, leads to
an elegant set of constraints that can be used in a genome-
scale analysis. We used an existing genome-scale model [18]
with a set rate of haemoglobin consumption (assuming a
75 % consumption of total haemoglobin in 48-h [31]) and
optimized for biomass production, only allowing uptake of
the amino acids isoleucine and arginine. Isoleucine is not
present in haemoglobin and must be taken up from the blood.
P. falciparum is known to convert arginine to ornithine [32],
leading to hypoargininaemia [25]. Under these conditions,
a specific growth rate of 0.049 h− 1 was calculated for P.
falciparum, which is close to the expected value of 0.058 h− 1
(calculated on the basis of 16 merozoites formed in 48-h).
A glucose consumption rate of 1.6 mmol·h− 1·gDW− 1 was
obtained which is somewhat lower than the experimentally
measured value of 2.1 mmol·h− 1·gDW− 1 [33].
The complete set of reactions for the genome-scale
network is shown in Figure 2(A), where the red lines
indicate the fluxes through the reactions. In Figure 2(B),
a subset of reactions involved in amino acid metabolism is
shown. These reactions fall in three classes: (1) degradation
of haemoglobin, (2) the synthesis of biomass and (3) export
and inter-conversion of amino acids. The export fluxes for
the amino acids are indicated in Figure 2(C).
The relative amino acid production rates compare well with
rates observed in P. falciparum culture [32]. Note that the
arginine to ornithine conversion was part of the objective
and is therefore not a validation for the model. One cannot
immediately compare these amino acid product formation
rates to changes in blood amino acid concentrations in malaria
patients since these concentrations are also dependent on the
consumption rates in the body. However, the high capacity
of the network to consume arginine and the high alanine
production rates are in good agreement with the observed
hypoargininaemia and high alanine blood concentrations
in malaria patients. Interestingly, a high alanine blood
concentration in malaria patients is usually attributed to a
reduced alanine to glucose conversion in the liver [26], but
our network analysis shows that a high alanine production
by Plasmodium could contribute to this symptom. For an
accurate prediction of blood concentration changes of amino
acids a full body implementation of a model is required.
However, high production rates (e.g. alanine) or consumption
rates (e.g. arginine) due to Plasmodium activity can point to
potential metabolic biomarkers for malaria progression. In
addition, one can simulate the effect of a drug by setting
a constraint on a metabolic flux in the network. If such
an inhibition is complete then the network analysis can be
accurate and the effect is dependent on whether the inhibited
step is essential or not. If the inhibition is not complete, which
is the likely scenario, it is better to analyse the effect in a
kinetic model.
Kinetic modelling of Plasmodium glucose
metabolism in malaria patients
Currently no detailed kinetic models exist for genome-
scale networks, mostly due to limited kinetic informa-
tion. Kinetic models do exist for smaller systems, such
as central carbon metabolism and in a more coarse-
grained form for organ and organism level metabolism.
To analyse the effect of increased glycolytic activity of
Plasmodium infected red blood cells in malaria patients,
we merged three existing kinetic models: a detailed
kinetic model for glycolysis of P. falciparum [34], a
detailed kinetic model for central carbon metabolism of the
red blood cell [35–37] and a coarse grained kinetic model
for whole-body glucose metabolism [38]. The models were
obtained from the JWS Online [39] and Biomodels [40] model
repositories, corrected for units and shared-variable-names
inconsistencies and integrated. No adaptations were made to
the P. falciparum and red blood cell model and for the whole-
body model only the fixed metabolites alanine and non-
esterified fatty acids were changed. A detailed description
of the merged model will be published elsewhere (K. Green,
D.C. Palm, F. du Toit and D.D. van Niekerk and Snoep,
manuscript in preparation).
Figure 3(A) shows a schema for the combined model
with the compartmentalized whole-body model and the
added Plasmodium infected red blood model. A simulation
of the effect of increased parasitaemia on blood glucose
concentration is given in Figure 3(B), together with patient
data (and rat model data) obtained from the literature.
The patient data show a lot of scatter, which is indicative
of large intermittent variance (no longitudinal data for a
patient followed over time was available). Most papers make
reference to hypoglycaemia in severe malaria patients, but
then do not report both parasitaemia and blood glucose levels.
The model prediction does simulate the reference state and
the few patient data with hypoglycaemia, for which data were
C©2015 Authors; published by Portland Press Limited
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Figure 2 P. falciparum genome-scale network analysis
The steady state solution space for the genome-scale metabolic network for P. falciparum [18] with a set influx rate of
0.83 μmol haemoglobin·h− 1·gDW− 1 was optimized for biomass formation and ornithine production. Fluxes are indicated in
red on the complete network structure in (A). A subset of reactions for amino acid metabolism, indicating the haemoglobin
degradation, biomass formation and the amino acid inter-conversion and export are indicated in (B). The export fluxes of
the different amino acids are indicated in (C).
available, quite well. Similarly, the lactate data for malaria
patients shows a lot of scatter (Figure 3C) and much more
consistent data for the longitudinal rat study was obtained.
The model prediction of lactate is low for the reference
state but seems to follow the trend of lactate increase (and
the rat data) reasonably well. In Figure 3(D), the results of
an inhibition of the glucose transporter (to 50 % of non-
inhibited lactate flux) in P. falciparum are simulated.
Discussion and conclusion
To understand the pathophysiology of complex diseases,
whole-body mathematical models can be strong tools to
integrate and analyse the numerous effects that lead to
the disease state. Specifically, when personal parameters
can be added to such a model, they can be instrumental
in choosing a correct treatment. Currently only very few
molecularly informed models exist for the whole-body level
C©2015 Authors; published by Portland Press Limited
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Figure 3 Modelling glucose and lactate metabolism in malaria patients
(A) kinetic model for whole-body glucose metabolism [38] was merged with two detailed kinetic models for glucose
metabolism in P. falciparum [34] and the red blood cell [35–37] (A). The effect of increasing levels of parasitaemia on
steady state blood glucose and lactate concentrations was analysed and shown in (B and C) respectively, together with
concentrations measured in malaria patients (black symbols, calculated from [41–52]) and rat data (red symbols, calculated
from [53]). The shaded boxes indicate the severe malaria (> 5 % parasitaemia) and hypoglycaemia (<2 mM glucose, B)
and lactic acidosis (>5 mM lactate, C) areas. (D) The effect of inhibition of the glucose transport step (starting at t = 50 min,
resulting in 50 % reduction in glycolytic flux in the parasite) on blood glucose and lactate concentrations in a malaria patient
(5 % parasitaemia) was simulated.
that are detailed enough to be useful in medical applications
(e.g. http://www.entelos.com). Specifically for the simulation
of pharmacological drug effects on the disease state there
is a big challenge in terms of modelling at the correct
level of detail. To simulate the drug effect at the reaction
step, a high level of detail is needed at the drug target
level, which cannot be sustained up to the whole-body
level.
C©2015 Authors; published by Portland Press Limited
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In the present paper, we illustrated how a hierarchical
model, with a high level of detail at the drug target site and
more coarse-grained for the whole-body level, can be used
to simulate the effect of a pharmaceutical drug on blood
glucose concentration. Clearly, the model is still in a very
rudimentary stage; we only simulate the direct metabolic
effect of parasite activity and have ignored any effects on
blood perfusion or reduced red blood cell contents due to
cell lysis or any of the large number of secondary effects
caused by the malaria parasites. In addition, we simulated
the drug effect by simply assuming a constant inhibitor
concentration in the blood, a much more realistic simulation
would have to include a full PK/PD (pharmacokinetics/
pharmacodynamics) model to evaluate the drug efficacy
[5,54].
The aim to mechanistically simulate drug effects (inhibiting
a specific target reaction) at the whole-body level (physiolo-
gical disease state) is very ambitious. However, we feel the
time is right for this. Some large-scale projects have existed
for quite some time and produced detailed kinetic models at
the organ level that can be extended to the whole-body level
(e.g. the physiome project, http://physiomeproject.org [55];
the virtual liver, http://www.virtual-liver.de [56]). In addition,
a much stronger adherence to modelling standards, such as
description in standard formats [systems biology markup
language (SBML) and CellML)] and storage in curated model
databases (JWS Online, Biomodels and CellML), makes
model reuse much easier. For our initial model construction,
we merged three existing models and this enabled us to make
some preliminary simulations at different hierarchical levels.
Of course, one cannot simple merge all existing models; they
must be compatible and constructed for similar physiological
conditions [57]. After merging of existing models, one can
start a number of iterative cycles to improve the integral
model and adapt it to specific disease states.
With the present concept paper, we hope to have illustrated
the approach we follow towards whole-body modelling of
blood glucose and lactate metabolism in malaria patients.
Clearly, much work is still needed and especially at the whole-
body level the model needs to be validated more thoroughly.
For this, we will first work in a rat model system for which
it is much easier to obtain longitudinal data. Although the
specific model for malaria patients is still very preliminary,
the suggested approach of a hierarchical model structure
with a high level of detail at the drug target level and more
coarse-grained models at the whole-body physiological level,
is generic and could be applied to other complex metabolic
diseases such as type II diabetes.
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